Unnamed: 0,title,date,stock,sentiment
357278.0,"Benzinga's Top Upgrades, Downgrades For June 9, 2020",2020-06-09 09:45:00-04:00,DGX,positive
357279.0,10 Biggest Price Target Changes For Tuesday,2020-06-09 08:15:00-04:00,DGX,neutral
357280.0,"Wells Fargo Upgrades Quest Diagnostics to Equal-Weight, Raises Price Target to $120",2020-06-09 06:16:00-04:00,DGX,positive
357281.0,"IQVIA, Quest Diagnostics Report Their Joint Venture, Q2 Solutions, Partnered With Thermo Fisher Scientific To Use Ion Torrent Genexus System Sequencing Platform To Deliver Clinical Trial Lab Results",2020-06-03 08:23:00-04:00,DGX,positive
357282.0,"Deutsche Bank Reinstates Buy on Quest Diagnostics, Announces $140 Price Target",2020-06-02 07:22:00-04:00,DGX,neutral
357283.0,Quest Diagnostics Says Specimens Will Ship Overnight Via FedEx At Room Temperature Without Frozen Cold Pack,2020-05-28 13:11:00-04:00,DGX,neutral
357284.0,"Quest Diagnostics Says More Than 500K Self-Collection Kits To Be Available By End Of June; Will Make Device Available Through Broad Range Of Healthcare, State, Employer And Consumer-initiated Channels",2020-05-28 13:10:00-04:00,DGX,neutral
357285.0,FDA Authorizes Quest Diagnostics COVID-19 Coronavirus Nasal Specimen Self-Collection Kit For Emergency Use,2020-05-28 13:09:00-04:00,DGX,negative
357286.0,Quest Diagnostics Recent Press Release Highlights Launch Of New Suite Of Return To Work Services Built Around Large-Scale Workforce Coronavirus Testing,2020-05-27 09:53:00-04:00,DGX,neutral
357287.0,Quest Diagnostics Launches COVID-19 Workforce Testing Services to Help Guide Organizations in Fostering Safer Workplaces as Employees Return to Work,2020-05-27 09:29:00-04:00,DGX,positive
357288.0,"SunTrust Robinson Humphrey Maintains Hold on Quest Diagnostics, Raises Price Target to $130",2020-05-21 09:05:00-04:00,DGX,neutral
357289.0,Why Quest Diagnostics Is Trading Higher Today,2020-05-20 11:29:00-04:00,DGX,neutral
357290.0,Quest Diagnostics shares are trading higher after Morgan Stanley maintained an Overweight rating and raised its price target from $139 to $146.,2020-05-20 09:52:00-04:00,DGX,negative
357291.0,"Morgan Stanley Maintains Overweight on Quest Diagnostics, Raises Price Target to $146",2020-05-20 08:10:00-04:00,DGX,negative
357292.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,DGX,negative
357293.0,Ortho Clinical Diagnostics And Quest Diagnostics To 'Broaden Availability of COVID-19 Antibody Testing',2020-05-11 08:01:00-04:00,DGX,neutral
357294.0,"UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $111",2020-05-05 10:27:00-04:00,DGX,neutral
357295.0,"B of A Securities Reiterates Neutral on Quest Diagnostics, Raises Price Target to $120",2020-04-30 08:32:00-04:00,DGX,positive
357296.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,DGX,positive
357297.0,"Centene, Quest Diagnostics Report Collaboration To Increase Access To Real-Time Reverse Transciprition Polymerase Chain Reaction Coronavirus Testing",2020-04-29 07:13:00-04:00,DGX,positive
357298.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-28 10:18:00-04:00,DGX,neutral
357299.0,10 Biggest Price Target Changes For Tuesday,2020-04-28 08:10:00-04:00,DGX,neutral
357300.0,Quest Diagnostics shares are trading higher after the company announced it has launched consumer-initiated coronavirus antibody testing kits online. Morgan Stanley also upgraded the company stocks from Equal-Weight to Overweight and raised its price target from $95 to $139.,2020-04-28 07:11:00-04:00,DGX,positive
357301.0,Quest Diagnostics Launches Consumer-Initiated COVID-19 Antibody Test Through QuestDirect,2020-04-28 07:08:00-04:00,DGX,neutral
357302.0,"Morgan Stanley Upgrades Quest Diagnostics to Overweight, Raises Price Target to $139",2020-04-28 06:02:00-04:00,DGX,negative
357303.0,"Quest Diagnostics CEO Speaking At Press Conference, Says Currently Doing 50K Tests Per Day, By End Of May Will Have 100K Per Day",2020-04-27 17:45:00-04:00,DGX,neutral
357304.0,Why Quest Diagnostics Is Trading Higher Today,2020-04-27 10:59:00-04:00,DGX,neutral
357305.0,Quest Diagnostics shares are trading higher after analysts at Citigroup upgraded the company's stock from Neutral to Buy and raised the price target from $113 to $130.,2020-04-27 09:52:00-04:00,DGX,positive
357306.0,"Benzinga's Top Upgrades, Downgrades For April 27, 2020",2020-04-27 09:32:00-04:00,DGX,positive
357307.0,10 Biggest Price Target Changes For Monday,2020-04-27 08:28:00-04:00,DGX,neutral
357308.0,"Citigroup Upgrades Quest Diagnostics to Buy, Raises Price Target to $130",2020-04-27 07:35:00-04:00,DGX,neutral
357309.0,Pentagon Officials Don't Expect to Have Enough Tests for All Service Members Until Sometime This Summer,2020-04-26 09:00:00-04:00,DGX,neutral
357310.0,"JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $111",2020-04-23 09:17:00-04:00,DGX,positive
357311.0,"Wells Fargo Maintains Underweight on Quest Diagnostics, Raises Price Target to $90",2020-04-23 08:24:00-04:00,DGX,positive
357312.0,"Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $99",2020-04-23 07:25:00-04:00,DGX,neutral
357313.0,"CFRA Downgrades Quest Diagnostics to Hold, Lowers Price Target to $106",2020-04-22 14:02:00-04:00,DGX,negative
357314.0,Quest Diagnostics: Q1 Earnings Insights,2020-04-22 09:35:00-04:00,DGX,neutral
357315.0,"The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership",2020-04-22 07:51:00-04:00,DGX,negative
357316.0,Quest Diagnostics shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-22 07:28:00-04:00,DGX,positive
357317.0,"Quest Diagnostics Q1 Adj. EPS $0.940 Beats $0.900 Estimate, Sales $1.822B Beat $1.760B Estimate",2020-04-22 06:45:00-04:00,DGX,neutral
357318.0,"Earnings Scheduled For April 22, 2020",2020-04-22 04:07:00-04:00,DGX,neutral
357319.0,Quest Diagnostics Highlights Has Begun Performing Antibody Testing For Coronavirus Using Blood Samples,2020-04-21 17:46:00-04:00,DGX,neutral
357320.0,"The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision",2020-04-19 17:22:00-04:00,DGX,positive
357321.0,Shares of several healthcare companies are trading higher amid optimistic coronavirus outlook following positive drug data from Gilead. This has raised hopes of a sooner return to spending and economic activity.,2020-04-17 10:04:00-04:00,DGX,positive
357322.0,"Mizuho Maintains Buy on Quest Diagnostics, Lowers Price Target to $106",2020-04-16 11:48:00-04:00,DGX,negative
357323.0,Shares of several healthcare companies are trading lower amid overall market weakness caused by the coronavirus which has decreased consumer spending and economic activity.,2020-04-15 10:05:00-04:00,DGX,negative
357324.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,DGX,positive
357325.0,"Quest Diagnostics 8-K Shows Letter From Chair, CEO, Pres To Employees, Outlines Added Temporary Changes To Co.'s Business/Operations",2020-04-13 16:39:00-04:00,DGX,neutral
357326.0,Quest Diagnostics shares are trading lower after SunTrust Robinson Humphrey maintained its Hold rating on the stock and lowered its price target from $115 to $100 per share.,2020-04-13 12:46:00-04:00,DGX,positive
357327.0,"SunTrust Robinson Humphrey Maintains Hold on Quest Diagnostics, Lowers Price Target to $100",2020-04-13 09:13:00-04:00,DGX,negative
357328.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,DGX,positive
357329.0,CareDx Reports Collaboration With Quest Diagnostics' ExamOne To Expand Mobile Phlebotomy Coverage Across US,2020-04-09 07:03:00-04:00,DGX,positive
357330.0,"Cramer Advises His Viewers On New Residental, Prudential Financial And More",2020-04-07 09:44:00-04:00,DGX,neutral
357331.0,"The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation",2020-04-07 07:55:00-04:00,DGX,negative
357332.0,Shares of several healthcare companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-07 07:48:00-04:00,DGX,positive
357333.0,"JP Morgan Maintains Neutral on Quest Diagnostics, Lowers Price Target to $87",2020-04-02 12:16:00-04:00,DGX,positive
357334.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,DGX,negative
357335.0,Quest Diagnostics Says Currently Doing 30K Coronavirus Tests/Day,2020-03-31 16:47:00-04:00,DGX,neutral
357336.0,"Quest Diagnostics Says In March, Experienced, & Anticipates Will Continue To Experience, A Material Decline In Testing Volumes Due To Coronavirus Pandemic",2020-03-31 16:46:00-04:00,DGX,neutral
357337.0,"Wells Fargo Maintains Underweight on Quest Diagnostics, Lowers Price Target to $80",2020-03-30 12:40:00-04:00,DGX,positive
357338.0,Quest Diagnostics shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight.,2020-03-27 09:37:00-04:00,DGX,negative
357339.0,"Morgan Stanley Downgrades Quest Diagnostics to Equal-Weight, Announces $95 Price Target",2020-03-27 05:03:00-04:00,DGX,neutral
357340.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,DGX,positive
357341.0,"Barclays Maintains Equal-Weight on Quest Diagnostics, Lowers Price Target to $93",2020-03-26 11:06:00-04:00,DGX,negative
357342.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,DGX,negative
357343.0,"IQVIA, Quest Diagnostics Joint Venture, Q2 Solutions, Reports Collaboration With University Of Texas Medical Branch To Develop Assay For Coronavirus Tests",2020-03-24 08:20:00-04:00,DGX,positive
357344.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,DGX,negative
357345.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,DGX,negative
357346.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-19 10:49:00-04:00,DGX,negative
357347.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,DGX,positive
357348.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,DGX,negative
357349.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,DGX,negative
357350.0,"Trump Declares National Emergency Over Coronavirus Pandemic, Promises More Tests Next Week",2020-03-13 16:45:00-04:00,DGX,neutral
357351.0,Quest Diagnostics Exec Comes To Podium,2020-03-13 15:48:00-04:00,DGX,neutral
357352.0,Quest Diagnostics Exec Comes To Podium,2020-03-13 15:48:00-04:00,DGX,neutral
357353.0,"Pence Talks Telemedicine, Co-Pays In Coronavirus Update",2020-03-11 12:15:00-04:00,DGX,neutral
357354.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,DGX,neutral
357355.0,"VOA Reporter Steve Herman Tweet: ""We have a surplus capacity already of tests that have been produced,"" says @SecAzar",2020-03-10 18:17:00-04:00,DGX,neutral
357356.0,Afternoon Market Stats In 5 Minutes,2020-03-10 15:23:00-04:00,DGX,neutral
357357.0,Quest Diagnostics shares are trading lower. Not currently seeing company-specific news.,2020-03-10 11:07:00-04:00,DGX,neutral
357358.0,"Labcorp, Quest Diagnostics Shares Unaffected As Hearing CDC Director Redfield Says Coronavirus Lab Testing Is Now Available For Any US Doctor Who Uses Labcorp, Quest",2020-03-10 10:40:00-04:00,DGX,positive
357359.0,Morning Market Stats In 5 Minutes,2020-03-09 11:22:00-04:00,DGX,neutral
357360.0,"FDA's Hahn Says 5,861 Coronavirus Tests Done in U.S. So Far",2020-03-07 14:47:00-05:00,DGX,neutral
357361.0,FDA Head Says 1.1M Coronavirus Tests Shipped to Non-public Health Labs; Says Another 1M Coronavirus Tests Will Be Shipped to Non-public Labs by Monday; Manufacturers Told FDA They Believe They Could Scale Up by the End of Next Week to Capacity of 4M Additional Tests,2020-03-07 14:44:00-05:00,DGX,neutral
357362.0,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study",2020-03-06 08:49:00-05:00,DGX,negative
357363.0,"CFRA Upgrades Quest Diagnostics to Strong Buy, Raises Price Target to $140",2020-03-05 12:14:00-05:00,DGX,positive
357364.0,Stocks That Hit 52-Week Highs On Thursday,2020-03-05 10:18:00-05:00,DGX,neutral
357365.0,Quest Diagnostics Highlights Launch Of Coronavirus Test,2020-03-05 09:06:00-05:00,DGX,neutral
357366.0,"The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19",2020-03-05 08:05:00-05:00,DGX,negative
357367.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,DGX,positive
357368.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears.,2020-03-02 11:18:00-05:00,DGX,positive
357369.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,DGX,negative
357370.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-19 10:32:00-05:00,DGX,neutral
357371.0,"Mizuho Maintains Buy on Quest Diagnostics, Raises Price Target to $122",2020-02-10 07:59:00-05:00,DGX,neutral
357372.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,DGX,negative
357373.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,DGX,neutral
357374.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,DGX,neutral
357375.0,"Citigroup Maintains Neutral on Quest Diagnostics, Raises Price Target to $113",2020-02-03 08:34:00-05:00,DGX,neutral
357376.0,"B of A Securities Maintains Neutral on Quest Diagnostics, Raises Price Target to $116",2020-01-31 11:41:00-05:00,DGX,positive
357377.0,"Baird Maintains Outperform on Quest Diagnostics, Raises Price Target to $118",2020-01-31 09:12:00-05:00,DGX,neutral
357378.0,"The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO",2020-01-31 09:09:00-05:00,DGX,negative
357379.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-30 10:25:00-05:00,DGX,neutral
357380.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,DGX,positive
357381.0,Quest Diagnostics Sees FY20 Adj. EPS Greater Than $6.60,2020-01-30 06:47:00-05:00,DGX,positive
357382.0,"Quest Diagnostics Q4 Adj. EPS $1.67 Beats $1.6 Estimate, Sales $1.93B Beat $1.92B Estimate",2020-01-30 06:46:00-05:00,DGX,neutral
357383.0,"Earnings Scheduled For January 30, 2020",2020-01-30 04:59:00-05:00,DGX,neutral
357384.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,DGX,neutral
357385.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-28 11:05:00-05:00,DGX,neutral
357386.0,"The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics",2020-01-28 07:12:00-05:00,DGX,positive
357387.0,Quest Diagnostics to Acquire Assets of Memorial Hermann Diagnostic Laboratories; No Terms Disclosed,2020-01-27 14:47:00-05:00,DGX,negative
357388.0,Quest Diagnostics And Memorial Hermann Health Systems Will Have A Long-Term Collaboration To Broaden Access For Innovative High-Value Lab Services,2020-01-27 14:39:00-05:00,DGX,positive
357389.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,DGX,neutral
357390.0,"Quest Diagnostics Acquires Blueprint Genetics, Terms Not Disclosed",2020-01-22 06:01:00-05:00,DGX,neutral
357391.0,Enzo Biochem Responds to Statements From Activist Hedge Fund Harbert,2020-01-13 08:09:00-05:00,DGX,neutral
357392.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,DGX,positive
357393.0,"Wells Fargo Initiates Coverage On Quest Diagnostics with Underweight Rating, Announces $100 Price Target",2020-01-08 09:05:00-05:00,DGX,positive
357394.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2020",2020-01-03 11:33:00-05:00,DGX,positive
357395.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,DGX,positive
357396.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-19 10:29:00-05:00,DGX,neutral
357397.0,"Benzinga's Top Upgrades, Downgrades For December 19, 2019",2019-12-19 09:51:00-05:00,DGX,positive
357398.0,Bank of America Upgrades Quest Diagnostics to Neutral,2019-12-19 06:49:00-05:00,DGX,neutral
357399.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-27 10:14:00-05:00,DGX,neutral
357400.0,"Quest Diagnostics Sees FY19 Adj. EPS $6.45-$6.50 vs $6.50 Est., Sales ~$7.72B vs $7.71B Est.",2019-10-22 06:47:00-04:00,DGX,neutral
357401.0,"Quest Diagnostics Q3 Adj. EPS $1.76 Beats $1.71 Estimate, Sales $1.96B Beat $1.94B Estimate",2019-10-22 06:45:00-04:00,DGX,neutral
357402.0,"UBS Maintains Neutral on Quest Diagnostics, Lowers Price Target to $102",2019-10-21 08:05:00-04:00,DGX,negative
357403.0,"Morgan Stanley Maintains Overweight on Quest Diagnostics, Raises Price Target to $121",2019-08-23 08:31:00-04:00,DGX,negative
357404.0,"JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $111",2019-07-24 08:57:00-04:00,DGX,positive
357405.0,"Morgan Stanley Maintains Overweight on Quest Diagnostics, Raises Price Target to $111",2019-07-24 08:15:00-04:00,DGX,negative
357406.0,"Canaccord Genuity Maintains Buy on Quest Diagnostics, Raises Price Target to $112",2019-07-24 08:13:00-04:00,DGX,neutral
357407.0,"Credit Suisse Maintains Neutral on Quest Diagnostics, Raises Price Target to $105",2019-07-24 07:54:00-04:00,DGX,positive
357408.0,60 Biggest Movers From Yesterday,2019-07-24 04:57:00-04:00,DGX,neutral
357409.0,45 Stocks Moving In Tuesday's Mid-Day Session,2019-07-23 13:09:00-04:00,DGX,neutral
357410.0,Quest Diagnostics shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.,2019-07-23 09:53:00-04:00,DGX,positive
357411.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,DGX,negative
357412.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings,2019-07-23 07:06:00-04:00,DGX,positive
357413.0,Quest Diagnostics Reaffirms FY19 Sales Guidance Of $7.60B-$7.75B vs $7.69B Est.,2019-07-23 06:57:00-04:00,DGX,neutral
357414.0,"Quest Diagnostics Q2 Adj. EPS $1.73 Beats $1.68 Estimate, Sales $1.953B Beat $1.94B Estimate",2019-07-23 06:56:00-04:00,DGX,neutral
357415.0,"Earnings Scheduled For July 23, 2019",2019-07-23 04:51:00-04:00,DGX,neutral
357416.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,DGX,neutral
357417.0,Quest Diagnostics shares are trading lower after Goldman Sachs downgraded the company's stock from Neutral to Sell and lowered the price target from $90 to $85.,2019-07-15 13:20:00-04:00,DGX,negative
357418.0,"Benzinga's Top Upgrades, Downgrades For July 15, 2019",2019-07-15 09:38:00-04:00,DGX,positive
357419.0,UPDATE: Roth Sees News Sharecare Named Quest Diagnostics As A Preferred Lab Partner And Strategic Investment Potentially Setting The Stage For An IPO Going Forward,2019-07-15 09:37:00-04:00,DGX,neutral
357420.0,"UPDATE: Roth Sees Remark's Sharecare Stake As Worth ~$43M, Or $3.65-$4.31/Share",2019-07-15 09:36:00-04:00,DGX,positive
357421.0,Roth Capital Sees Remark Holdings' ~4.5% Sharecare Stake Likely Worth Multiples Of Current Entire Market Cap,2019-07-15 09:35:00-04:00,DGX,positive
357422.0,"Goldman Sachs Downgrades Quest Diagnostics to Sell, Lowers Price Target to $85",2019-07-15 06:50:00-04:00,DGX,negative
357423.0,This Day In Market History: First Draft Of Human Genome Completed,2019-06-26 07:15:00-04:00,DGX,neutral
357424.0,"Quest Diagnostics Says On May 14, American Medical Collection Agency Notified Co, Optum360 Of Potential Unauthorized Activity On Amca's Web Payment Page; Says ~11.9M Patients Affected Quest Says Suspended Sending Collection Requests to AMCA",2019-06-03 06:23:00-04:00,DGX,negative
357425.0,"Morgan Stanley Maintains Overweight on Quest Diagnostics Incorporated Common Stock, Raises Price Target to $104",2019-04-25 09:06:00-04:00,DGX,negative
357426.0,"Canaccord Genuity Maintains Buy on Quest Diagnostics Incorporated Common Stock, Raises Price Target to $103",2019-04-24 08:37:00-04:00,DGX,neutral
357427.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,DGX,positive
357428.0,Quest Diagnostics shares are trading higher after the company reported better-than-expected Q1 EPS and sales; the company also reaffirmed FY19 guidance roughly in line with analyst estimates.,2019-04-23 09:47:00-04:00,DGX,positive
357429.0,"Quest Diagnostics Reaffirms FY19 Guidance: Adj. EPS Greater Than $6.40 vs $6.45 Estimate, Sales $7.6B-$7.75B vs $7.68B Est.",2019-04-23 06:47:00-04:00,DGX,positive
357430.0,"Quest Diagnostics Q1 Adj. EPS $1.4 Beats $1.36 Estimate, Sales $1.891B Beat $1.87B Estimate",2019-04-23 06:46:00-04:00,DGX,neutral
357431.0,"Earnings Scheduled For April 23, 2019",2019-04-23 04:00:00-04:00,DGX,neutral
357432.0,Shares of several healthcare companies are trading lower after Trump renewed his efforts to repeal and replace the Affordable Care Act; the Department of Justice moved to accelerate the appeal process in hopes to invalidate the ACA as unconstitutional.BZ,2019-04-17 13:02:00-04:00,DGX,positive
357433.0,"UPDATE: Jefferies Upgrades Quest Diagnostics And Laboratory Corp. As Firm Believes 'UNH's upcoming rollout of its preferred lab network is a positive catalyst for both stocks, as their likely inclusion should bolster organic growth beginning in 2020'",2019-04-02 09:21:00-04:00,DGX,positive
357434.0,"Benzinga's Top Upgrades, Downgrades For April 2, 2019",2019-04-02 09:13:00-04:00,DGX,positive
357435.0,Jefferies Upgrades Quest Diagnostics to Buy,2019-04-02 06:31:00-04:00,DGX,neutral
357436.0,"Benzinga's Top Upgrades, Downgrades For March 16, 2019",2019-03-18 08:53:00-04:00,DGX,positive
357437.0,Credit Suisse Downgrades Quest Diagnostics to Neutral,2019-03-18 08:07:00-04:00,DGX,positive
357438.0,71 Biggest Movers From Yesterday,2019-02-15 04:59:00-05:00,DGX,neutral
357439.0,52 Stocks Moving In Thursday's Mid-Day Session,2019-02-14 12:27:00-05:00,DGX,neutral
357440.0,"Quest Diagnostics shares are trading lower after the company reported Q4 EPS of $1.36, missing the $1.37 estimate and sales of $1.84 billion missing the $1.88 billion estimate; the company also issued weak FY19 guidance.",2019-02-14 10:43:00-05:00,DGX,negative
357441.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data",2019-02-14 07:29:00-05:00,DGX,neutral
357442.0,"Quest Diagnostics Sees FY19 Adj. EPS Greater Than $6.40 vs $6.56 Estimate, Sales $7.6B-$7.75B vs $7.76B Est.",2019-02-14 06:53:00-05:00,DGX,positive
357443.0,"Quest Diagnostics Q4 EPS $1.36 Misses $1.37 Estimate, Sales $1.839B Miss $1.88B Estimate",2019-02-14 06:52:00-05:00,DGX,negative
357444.0,"11 Stocks To Watch For February 14, 2019",2019-02-14 04:52:00-05:00,DGX,neutral
357445.0,"Earnings Scheduled For February 14, 2019",2019-02-14 04:21:00-05:00,DGX,neutral
357446.0,Argus Downgrades Quest Diagnostics to Hold,2019-01-31 08:47:00-05:00,DGX,neutral
357447.0,"UBS Initiates Coverage On Quest Diagnostics with Neutral Rating, Announces $90 Price Target",2019-01-17 08:03:00-05:00,DGX,neutral
357448.0,"Stocks Trading Ex Dividend For Mon., Jan. 14, 2019",2019-01-14 09:32:00-05:00,DGX,neutral
357449.0,"Stocks That Will Be Trading Ex Dividend Mon., Jan. 14, 2019",2019-01-11 12:34:00-05:00,DGX,neutral
357450.0,"Stocks Trading Ex Dividend For Fri., Jan. 11, 2019",2019-01-11 12:25:00-05:00,DGX,neutral
357451.0,Bank of America Downgrades Quest Diagnostics to Underperform,2019-01-03 08:09:00-05:00,DGX,neutral
357452.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,DGX,neutral
357453.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018",2018-12-20 11:33:00-05:00,DGX,negative
357454.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,DGX,negative
357455.0,"Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018",2018-12-17 11:48:00-05:00,DGX,negative
357456.0,10 Biggest Price Target Changes For Friday,2018-11-30 11:20:00-05:00,DGX,neutral
357457.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Nov. 29, 2018",2018-11-30 10:27:00-05:00,DGX,negative
357458.0,"Benzinga's Top Upgrades, Downgrades For November 30, 2018",2018-11-30 09:15:00-05:00,DGX,positive
357459.0,"Barclays Maintains Overweight on Quest Diagnostics, Lowers Price Target to $117",2018-11-30 08:36:00-05:00,DGX,negative
357460.0,"Credit Suisse Maintains Outperform on Quest Diagnostics, Lowers Price Target to $103",2018-11-30 07:59:00-05:00,DGX,positive
357461.0,"Morgan Stanley Maintains Overweight on Quest Diagnostics, Lowers Price Target to $107",2018-11-30 07:44:00-05:00,DGX,negative
357462.0,"Goldman Sachs Downgrades Quest Diagnostics to Neutral, Lowers Price Target to $90",2018-11-30 07:06:00-05:00,DGX,negative
357463.0,48 Biggest Movers From Yesterday,2018-11-30 05:39:00-05:00,DGX,neutral
357464.0,32 Stocks Moving In Thursday's Mid-Day Session,2018-11-29 12:42:00-05:00,DGX,neutral
357465.0,Quest Diagnostics shares fall after the company cut FY18 sales guidance.,2018-11-29 09:58:00-05:00,DGX,neutral
357466.0,"UPDATE: Quest Diagnostics Attributes Updated Revenue Guidance To ""volume softness, some of which is driven by Hurricane Michael, California wildfires, and the recent East Coast snowstorm.""",2018-11-28 16:37:00-05:00,DGX,neutral
357467.0,"Quest Diagnostics Reaffirms Goals Over Next 4 Years: Sales Growth 3-5%, Earnings Growth 4-6%",2018-11-28 16:36:00-05:00,DGX,positive
357468.0,Quest Diagnostics Raises Quarterly Dividend From $0.50 To $0.53/Share,2018-11-28 16:34:00-05:00,DGX,neutral
357469.0,"UPDATE: Quest Diagnostics Cuts FY18 Sales Guidance From $7.62B To $7.57B vs $7.62 Estimate, Adj. EPS From $6.53-$6.60 To Great Than $6.30 vs $6.56 Est.",2018-11-28 16:32:00-05:00,DGX,positive
357470.0,CORRECTION: Quest Diagnostics Cuts Guidance,2018-11-28 16:32:00-05:00,DGX,negative
357471.0,Quest Diagnostics Cuts FY18 Guidance,2018-11-28 16:31:00-05:00,DGX,negative
357472.0,"Quest Diagnostics Reports Purchase Of Boyce And Bynum Pathology Labs' Laboratory Services Unit, No Terms Disclosed",2018-11-27 09:02:00-05:00,DGX,negative
357473.0,"Delta, Skechers, Quest Diagnostics, XLF: 'Fast Money' Picks For November 21",2018-11-21 07:45:00-05:00,DGX,neutral
357474.0,"Credit Suisse Maintains Outperform on Quest Diagnostics, Lowers Price Target to $121",2018-10-24 11:47:00-04:00,DGX,positive
357475.0,"Barclays Maintains Overweight on Quest Diagnostics, Lowers Price Target to $125",2018-10-24 10:58:00-04:00,DGX,negative
357476.0,"Citigroup Maintains Neutral on Quest Diagnostics, Lowers Price Target to $104",2018-10-24 10:26:00-04:00,DGX,negative
357477.0,"Canaccord Genuity Maintains Buy on Quest Diagnostics, Lowers Price Target to $105",2018-10-24 10:17:00-04:00,DGX,negative
357478.0,"JP Morgan Maintains Neutral on Quest Diagnostics, Lowers Price Target to $107",2018-10-24 10:06:00-04:00,DGX,positive
357479.0,56 Biggest Movers From Yesterday,2018-10-24 05:53:00-04:00,DGX,neutral
357480.0,44 Stocks Moving In Tuesday's Mid-Day Session,2018-10-23 13:05:00-04:00,DGX,neutral
357481.0,"Quest Diagnostics Q3 Adj. EPS $1.68, Inline, Sales $1.89B Miss $1.95B Estimate",2018-10-23 06:53:00-04:00,DGX,negative
357482.0,"Earnings Scheduled For October 23, 2018",2018-10-23 04:22:00-04:00,DGX,neutral
357483.0,"Quest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation In Central Michigan, Financial Terms Not Disclosed",2018-10-22 09:30:00-04:00,DGX,positive
357484.0,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street,2018-10-08 06:26:00-04:00,DGX,negative
357485.0,"4 Stocks To Watch For October 8, 2018",2018-10-08 04:16:00-04:00,DGX,neutral
357486.0,"Quest Diagnostics To Sell India Diagnostics Business to Strand Life Sciences, No Terms Disclosed",2018-10-05 16:01:00-04:00,DGX,negative
357487.0,"Stocks That Will Trade Ex Dividend Thurs., Oct. 4, 2018",2018-10-03 16:55:00-04:00,DGX,neutral
357488.0,"Quest Diagnostics Reports Purchase Of PhenoPath, No Terms Disclosed",2018-09-27 09:01:00-04:00,DGX,negative
357489.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,DGX,positive
357490.0,Quest Diagnostics To Acquire U.S. Laboratory Services Business Of Oxford Immunotec,2018-09-25 09:04:00-04:00,DGX,neutral
357491.0,"Quest Diagnostics Acquires ReproSource, Terms Not Disclosed",2018-09-24 09:01:00-04:00,DGX,neutral
357492.0,"Argus Maintains Buy on Quest Diagnostics, Raises Price Target to $120",2018-09-14 09:37:00-04:00,DGX,neutral
357493.0,Hologic Downgraded By BofA As Cynosure Headwinds Persist,2018-09-13 11:01:00-04:00,DGX,neutral
357494.0,'California Assembly passes dialysis bill' -Axios,2018-08-30 07:27:00-04:00,DGX,neutral
357495.0,"Hooper Holmes Announces Asset Purchase Deal With Quest Diagnostics' Summit Health Unit For All Of Hooper's Assets, Total Value Of Deal $27M",2018-08-27 17:11:00-04:00,DGX,positive
357496.0,46 Biggest Movers From Yesterday,2018-07-25 04:03:00-04:00,DGX,neutral
357497.0,34 Stocks Moving In Tuesday's Mid-Day Session,2018-07-24 12:28:00-04:00,DGX,neutral
357498.0,"Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering",2018-07-24 08:53:00-04:00,DGX,positive
357499.0,25 Stocks Moving In Tuesday's Pre-Market Session,2018-07-24 08:02:00-04:00,DGX,neutral
357500.0,"Quest Diagnostics Raises FY18 Adj. EPS Outlook From $6.53-$6.67 To $6.50-$6.70 vs $6.61 Est., Raises Sales Outlook From $7.70B-$7.74B To $7.70-$7.77B vs $7.72B Est.",2018-07-24 06:52:00-04:00,DGX,neutral
357501.0,Quest Diagnostics Raises FY18 Outlook,2018-07-24 06:50:00-04:00,DGX,neutral
357502.0,"Quest Diagnostics Q2 Adj. EPS $1.75 Misses $1.76 Estimate, Sales $1.919B Miss $1.95B Estimate",2018-07-24 06:49:00-04:00,DGX,negative
357503.0,"Earnings Scheduled For July 24, 2018",2018-07-24 04:20:00-04:00,DGX,neutral
357504.0,Evercore ISI Group Upgrades Quest Diagnostics to Outperform,2018-07-10 09:26:00-04:00,DGX,neutral
357505.0,"Benzinga's Top Upgrades, Downgrades For June 27, 2018",2018-06-27 10:14:00-04:00,DGX,positive
357506.0,Deutsche Bank Downgrades Quest Diagnostics to Hold,2018-06-27 08:35:00-04:00,DGX,neutral
357507.0,"Benzinga's Daily Biotech Pulse: Epidiolex, Roche's Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results",2018-06-26 08:34:00-04:00,DGX,positive
357508.0,Quest Diagnostics Gets Positive Prognosis In Light Of UnitedHealth Partnership,2018-06-25 13:51:00-04:00,DGX,positive
357509.0,7 Biggest Price Target Changes For Monday,2018-06-25 09:44:00-04:00,DGX,neutral
357510.0,"Benzinga's Top Upgrades, Downgrades For June 25, 2018",2018-06-25 09:18:00-04:00,DGX,positive
357511.0,"Barclays Upgrades Quest Diagnostics to Overweight, Raises Price Target to $130",2018-06-25 07:28:00-04:00,DGX,negative
357512.0,Barclay's Upgrades Quest Diagnostics to Overweight from Equal-Weight; Raises PT to $130 from $120,2018-06-25 04:31:00-04:00,DGX,negative
357513.0,"The Market In 5 Minutes: China, ZTE, McDonald's And More",2018-06-08 09:00:00-04:00,DGX,neutral
357514.0,"Benzinga's Top Upgrades, Downgrades For June 8, 2018",2018-06-08 08:58:00-04:00,DGX,positive
357515.0,William Blair Upgrades Quest Diagnostics to Outperform,2018-06-08 07:41:00-04:00,DGX,neutral
357516.0,KeyBanc Projects 'Significant' Consolidation In Lab Testing Sector,2018-06-07 11:46:00-04:00,DGX,neutral
357517.0,"Labs Are 'Relative Safe Havens' In Health Care Services, Morgan Stanley Says In Quest Diagnostics Upgrade",2018-05-29 11:34:00-04:00,DGX,positive
357518.0,"Benzinga's Top Upgrades, Downgrades For May 29, 2018",2018-05-29 09:19:00-04:00,DGX,positive
357519.0,Morgan Stanley Upgrades Quest Diagnostics to Overweight,2018-05-29 07:15:00-04:00,DGX,negative
357520.0,Quest Diagnostics Shares Up 6.1% After Co. Late Thursday Announced  Long-Term Strategic Partnerships With UnitedHealthcare; Credit Suisse Maintains Outperform And Raises PT To $121,2018-05-25 11:52:00-04:00,DGX,positive
357521.0,"Credit Suisse Maintains Outperform on Quest Diagnostics, Raises Price Target to $121",2018-05-25 11:33:00-04:00,DGX,positive
357523.0,WHO Deems The Products Of These Diagnostic Companies 'Essential',2018-05-22 15:13:00-04:00,DGX,neutral
357524.0,"Lab Stocks: Baird Favors Laboratory Corp., Says Quest Diagnostics Is The Simple Choice",2018-05-01 16:28:00-04:00,DGX,positive
357525.0,Baird Assumes Quest Diagnostics at Outperform,2018-05-01 07:41:00-04:00,DGX,neutral
357526.0,"Quest Diagnostics Reaffirms FY18 Outlook: Sales $7.7B-$7.77B vs $7.75B Est., Adj. EPS $6.50-$6.70 vs $6.61 Est.",2018-04-19 06:48:00-04:00,DGX,neutral
357527.0,"Quest Diagnostics Q1 Adj. EPS $1.52 Beats $1.50 Est., Sales $1.88B Misses $1.9B Est.",2018-04-19 06:48:00-04:00,DGX,negative
357528.0,"Earnings Scheduled For April 19, 2018",2018-04-19 04:08:00-04:00,DGX,neutral
357529.0,"'It Could Be In Walmart's Best Interest To Act': Morgan Stanley Breaks Down Pros, Cons Of A Humana Deal",2018-04-02 10:47:00-04:00,DGX,positive
357530.0,"Humana, Quest Diagnostics and UnitedHealth Announce a Pilot Program to Apply Blockchain in Health Care",2018-04-02 09:01:00-04:00,DGX,positive
357531.0,5 Biggest Price Target Changes For Monday,2018-03-19 10:13:00-04:00,DGX,neutral
357532.0,"Canaccord Genuity Maintains Buy on Quest Diagnostics, Raises Price Target to $115.00",2018-03-19 08:49:00-04:00,DGX,neutral
357533.0,Morgan Stanley: Quest Diagnostics Has Balanced Risk-Reward,2018-03-14 11:26:00-04:00,DGX,neutral
357534.0,"Benzinga's Top Upgrades, Downgrades For March 14, 2018",2018-03-14 09:35:00-04:00,DGX,positive
357535.0,Morgan Stanley Upgrades Quest Diagnostics to Equal-Weight,2018-03-14 07:26:00-04:00,DGX,neutral
357536.0,"Argus Upgrades Quest Diagnostics, Cites Several Key Catalysts",2018-03-07 14:18:00-05:00,DGX,neutral
357537.0,"Benzinga's Top Upgrades, Downgrades For March 7, 2018",2018-03-07 09:16:00-05:00,DGX,positive
357538.0,Argus Upgrades Quest Diagnostics to Buy,2018-03-07 08:12:00-05:00,DGX,neutral
357539.0,"Benzinga's Top Upgrades, Downgrades For February 13, 2018",2018-02-13 09:22:00-05:00,DGX,positive
357540.0,Credit Suisse Upgrades Quest Diagnostics to Outperform,2018-02-13 07:15:00-05:00,DGX,positive
357541.0,"Credit Suisse Assumes Quest Diagnostics at Neutral, Announces $107.00 Price Target",2018-02-02 09:20:00-05:00,DGX,positive
357542.0,Quest Diagnostics Sees FY18 Adj. EPS $6.50-$6.70 vs $6.16 Est.,2018-02-01 06:47:00-05:00,DGX,neutral
357543.0,"Quest Diagnostics Reports Q4 Adj. EPS $1.40 vs $1.38 Est., Sales $1.94B vs $1.94B Est.",2018-02-01 06:46:00-05:00,DGX,neutral
357544.0,"Earnings Scheduled For February 1, 2018",2018-02-01 04:39:00-05:00,DGX,neutral
357545.0,"Goldman Sachs Assumes Quest Diagnostics at Buy, Announces price target $117.00",2018-01-29 09:09:00-05:00,DGX,neutral
357546.0,"Quest Diagnostics to Acquire MedXM, Terms Not Disclosed",2018-01-23 09:05:00-05:00,DGX,neutral
357547.0,"Evercore ISI Group Initiates Coverage On Quest Diagnostics with In-Line Rating, Announces $103.00 Price Target",2018-01-05 06:28:00-05:00,DGX,neutral
357548.0,Clinical Genomics and Quest Diagnostics Announce FDA 510(K) Clearance of InSure ONE,2017-11-13 08:06:00-05:00,DGX,neutral
357549.0,Quest Diagnostics Spikes to High of $93.70; Activity in Nov $95 Call,2017-11-09 11:10:00-05:00,DGX,neutral
357550.0,"Quest Diagnostics Acquires California Laboratory Associates, Terms Not Disclosed",2017-10-30 06:45:00-04:00,DGX,neutral
357551.0,"Quest Diagnostics Q3 Adj. $1.39 vs $1.35 Est., Sales $1.93B vs $1.92B Est.",2017-10-19 06:47:00-04:00,DGX,neutral
357552.0,"Earnings Scheduled For October 19, 2017",2017-10-19 04:04:00-04:00,DGX,neutral
357553.0,"Quest Diagnostics to Acquire Cleveland HeartLab, Terms Not Disclosed",2017-10-18 16:06:00-04:00,DGX,neutral
357554.0,"Benzinga's Top Upgrades, Downgrades For October 12, 2017",2017-10-12 09:14:00-04:00,DGX,positive
357555.0,"Wells Fargo Reinstates Market Perform on Quest Diagnostics, Announces $88.00 Price Target",2017-10-12 08:08:00-04:00,DGX,positive
357556.0,"Quest Diagnostics Reports Purchase Of Shiel Medical Lab From Fresenius Medical, No Terms Disclosed",2017-09-28 07:33:00-04:00,DGX,negative
357557.0,Quest Diagnostics Says It Expects Reduction Of Rev. By ~1.5% And Adj. EPS By ~$0.10 Due To Recent Hurricanes,2017-09-27 16:18:00-04:00,DGX,neutral
357558.0,Mid-Afternoon Market Update: Crude Oil Up Over 3%; AZZ Shares Plummet,2017-09-25 15:08:00-04:00,DGX,negative
357559.0,11 Biggest Mid-Day Losers For Monday,2017-09-25 12:57:00-04:00,DGX,negative
357560.0,Mid-Day Market Update: Dow Drops Over 100 Points; Aradigm Shares Spike Higher,2017-09-25 12:18:00-04:00,DGX,positive
357561.0,Mid-Morning Market Update: Markets Edge Lower; D. R. Horton Cuts Cash Flow Outlook,2017-09-25 10:23:00-04:00,DGX,negative
357562.0,The Market In 5 Minutes,2017-09-25 09:02:00-04:00,DGX,neutral
357563.0,"Benzinga's Top Upgrades, Downgrades For September 25, 2017",2017-09-25 09:00:00-04:00,DGX,positive
357564.0,20 Stocks Moving In Monday's Pre-Market Session,2017-09-25 08:07:00-04:00,DGX,neutral
357565.0,Raymond James Downgrades Quest Diagnostics to Market Perform,2017-09-25 06:25:00-04:00,DGX,neutral
357566.0,Quest Diagnostics Says Will Offer Cholesterol Testing without Need to Fast -Reuters,2017-09-07 06:17:00-04:00,DGX,neutral
357567.0,Hearing Quest Diagnostics Upgraded From Neutral To Buy At Bank of America,2017-07-25 13:05:00-04:00,DGX,neutral
357568.0,"Quest Diagnostics Raises Guidance, Sees FY 2017 EPS $5.62-$5.72 from $5.45-$5.60 vs $5.57 Est., Sees Sales $7.69B-$7.74B from $7.64B-$7.72B vs $7.69B Est.",2017-07-25 06:50:00-04:00,DGX,neutral
357569.0,"Quest Diagnostics Q2 EPS $1.55 vs $1.42 Est., Sales $1.94B vs $1.94B Est.",2017-07-25 06:49:00-04:00,DGX,neutral
357570.0,"Earnings Scheduled For July 25, 2017",2017-07-25 05:52:00-04:00,DGX,neutral
357572.0,"Quest Diagnostics To Acquire Cape Cod Healthcare Outreach Laboratory, Terms Not Disclosed",2017-06-27 13:01:00-04:00,DGX,positive
357573.0,Walmart To Partner With Quest Diagnostics To Offer In-Store Lab Work,2017-06-27 09:36:00-04:00,DGX,neutral
357577.0,"Quest Diagnostics Reports Acquisition Of 2 Texas Lab Businesses, Terms Not Disclosed",2017-06-12 16:05:00-04:00,DGX,neutral
357578.0,"Benzinga's Top Upgrades, Downgrades For May 12, 2017",2017-05-12 09:21:00-04:00,DGX,positive
357579.0,"Argus Initiates Coverage On Quest Diagnostics with Hold Rating, Announces $102.00 Price Target",2017-05-12 08:13:00-04:00,DGX,neutral
357580.0,The Market In 5 Minutes,2017-04-21 09:26:00-04:00,DGX,neutral
357581.0,"Benzinga's Top Upgrades, Downgrades For April 21, 2017",2017-04-21 09:23:00-04:00,DGX,positive
357582.0,Raymond James Upgrades Quest Diagnostics to Outperform,2017-04-21 07:35:00-04:00,DGX,neutral
357583.0,UPDATE: Quest Diagnostics Raises FY17 Adj. EPS to $5.45-$5.60 vs $5.46 Est.,2017-04-20 06:47:00-04:00,DGX,neutral
357584.0,Quest Diagnostics Raises FY17 Outlook,2017-04-20 06:46:00-04:00,DGX,neutral
357585.0,"Quest Diagnostics Reports Q1 Adj. EPS $1.33 vs $1.18 Est., Sales $1.9B vs $1.87B Est.",2017-04-20 06:46:00-04:00,DGX,neutral
357586.0,"Earnings Scheduled For April 20, 2017",2017-04-20 04:30:00-04:00,DGX,neutral
357587.0,Bank of America Upgrades Quest Diagnostics To Neutral,2017-03-16 09:27:00-04:00,DGX,neutral
357588.0,"UPDATE: Quest Will Buy Outreach Lab Services Operations of PeaceHealth Labs, No Terms Disclosed",2017-02-15 15:05:00-05:00,DGX,neutral
357589.0,"Quest Diagnostics, PeaceHealth Report Two-Part Arrangement for Enhancement of Delivery of Lab Services to Communities in Oregon, Washington, Alaska",2017-02-15 15:05:00-05:00,DGX,neutral
357590.0,Veracyte Reports Will Extend Access to Its Afirma GEC Through Deal with Quest Diagnostics,2017-02-08 08:09:00-05:00,DGX,positive
357591.0,"Quest Diagnostics Reports Q4 Adj. EPS $1.31 vs $1.27 Est., Sales $1.86B, Inline",2017-01-26 06:47:00-05:00,DGX,neutral
357592.0,"Earnings Scheduled For January 26, 2017",2017-01-26 06:03:00-05:00,DGX,neutral
357593.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,DGX,positive
357594.0,"Deutsche Bank Initiates Coverage On Quest Diagnostics At Buy, Announces $108 Price Target",2017-01-18 08:57:00-05:00,DGX,neutral
357595.0,Deutsche Bank Initiates Coverage on Medical Equipment Names,2017-01-17 17:59:00-05:00,DGX,neutral
357596.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2017",2017-01-03 09:20:00-05:00,DGX,positive
357597.0,Mizuho Upgrades Quest Diagnostics to Buy,2017-01-03 07:22:00-05:00,DGX,neutral
357598.0,"Quest Diagnostics Reports Notice of Data Security Incident: Unauthorized Third Party Accessed the MyQuest by Care360 App, Obtained Protected Health Info of ~34K Individuals",2016-12-12 17:04:00-05:00,DGX,positive
357599.0,Benzinga's Top Upgrades,2016-12-12 08:47:00-05:00,DGX,positive
357600.0,Goldman Sachs Upgrades Quest Diagnostics to Buy,2016-12-12 06:14:00-05:00,DGX,neutral
357601.0,18 Biggest Mid-Day Gainers For Monday,2016-11-14 12:30:00-05:00,DGX,neutral
357602.0,Benzinga's Top Upgrades,2016-11-14 08:46:00-05:00,DGX,positive
357603.0,UBS Upgrades Quest Diagnostics Incorporated Common Stock to Buy,2016-11-14 07:55:00-05:00,DGX,neutral
357604.0,"Quest Diagnostics Reaffirms FY16 Adj. EPS $5.07-$5.12 vs $5.10 Est., Sales ~$7.51B, Inline",2016-11-11 06:52:00-05:00,DGX,neutral
357605.0,"Quest Diagnostics Announces Will Expand Its Retail Presence in Safeway Stores to 50+ by End of This Year, to 200 by End of '17",2016-11-11 06:49:00-05:00,DGX,positive
357606.0,UPDATE: Quest Diagnostics Sees FY16 Sales Growth 3-5%,2016-11-11 06:48:00-05:00,DGX,positive
357607.0,Quest Diagnostics Raises Qtr. Dividend from $0.40 to $0.45/Share,2016-11-11 06:47:00-05:00,DGX,neutral
357608.0,Quest Diagnostics Raises Sales Growth Outlook,2016-11-11 06:47:00-05:00,DGX,positive
357609.0,The Healthcare Facility Space Just Got A Little Smaller,2016-10-31 15:09:00-04:00,DGX,neutral
357610.0,"Quest Diagnostics Sees FY EPS $5.07 to $5.12 vs $5.11 est, Revenue $7.51B vs $7.52B est",2016-10-20 06:46:00-04:00,DGX,neutral
357611.0,"Quest Diagnostics Q3 EPS $1.37 vs $1.35 est, Revenue $1.89B vs $1.89B est",2016-10-20 06:46:00-04:00,DGX,neutral
357612.0,"Earnings Scheduled For October 20, 2016",2016-10-20 04:07:00-04:00,DGX,neutral
357613.0,"7 Notable Stocks Trading Ex-Dividend Friday, September 30",2016-09-29 11:41:00-04:00,DGX,neutral
357614.0,Benzinga's Top Initiations,2016-09-09 09:12:00-04:00,DGX,positive
357615.0,"Citi Neutral On Lab Sector; Initiates On Quest Diagnostics, Labcorp",2016-09-09 09:12:00-04:00,DGX,neutral
357616.0,"Citigroup Initiates Coverage on Quest Diagnostics at Neutral, Announces $86.00 PT",2016-09-09 04:36:00-04:00,DGX,neutral
357617.0,Benzinga's Top Downgrades,2016-08-31 09:00:00-04:00,DGX,positive
357618.0,Mizuho Securities Downgrades Quest Diagnostics to Neutral,2016-08-31 05:47:00-04:00,DGX,positive
357619.0,Stocks Hitting 52-Week Highs,2016-07-21 10:52:00-04:00,DGX,neutral
357620.0,Quest Diagnostics Sees FY16 Ssales $7.47B-$7.54B vs $7.53B Est.,2016-07-21 06:47:00-04:00,DGX,neutral
357621.0,Quest Diagnostics Affirms FY16 Adj. EPS Outlook of $5.02-$5.17 vs $5.10 Est.,2016-07-21 06:46:00-04:00,DGX,neutral
357622.0,"Quest Diagnostics Reports Q2 Adj. EPS $1.34 vs $1.32 Est., Sales $1.91B, Inline",2016-07-21 06:45:00-04:00,DGX,neutral
357623.0,"Earnings Scheduled For July 21, 2016",2016-07-21 05:18:00-04:00,DGX,neutral
357624.0,Benzinga's Top Downgrades,2016-06-24 09:21:00-04:00,DGX,positive
357625.0,Jyske Bank Downgrades Quest Diagnostics to Sell,2016-06-24 08:01:00-04:00,DGX,neutral
357626.0,Quest Diagnostics Reveals Planned Senior Notes Offering For $500M,2016-05-23 14:18:00-04:00,DGX,neutral
357627.0,Quest Diagnostics Dividend Provides 2.10% Yield,2016-05-18 14:31:00-04:00,DGX,neutral
357628.0,"Quest Diagnostics Lowers FY 2016 Guidance, Sees Revneu $7.47B to $7.54B vs $7.55B est",2016-05-18 06:48:00-04:00,DGX,negative
357629.0,"Quest Diagnostics Sees FY 2016 EPS $5.02 to $5.17 vs $5.08 est, Revenue $7.52B to $7.59B vs $7.55B est",2016-04-21 06:47:00-04:00,DGX,neutral
357630.0,"Quest Diagnostics Q1 EPS $1.12 vs $1.12 est, Revenue $1.86B vs $1.82B est",2016-04-21 06:46:00-04:00,DGX,neutral
357631.0,Quest Diagnostics Reports Launch of New Hep C Virus Test Capabilities for Recently FDA-Approved Antiviral Therapies,2016-04-14 16:07:00-04:00,DGX,neutral
357632.0,Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies,2016-04-14 16:06:00-04:00,DGX,neutral
357633.0,DiaSorin To Acquire Focus Diagnostics' Business From Quest Diagnostics for $300M,2016-03-30 14:44:00-04:00,DGX,neutral
357634.0,Quest Diagnostics to Sell Focus Diagnostics for $300M Cash to DiaSorin,2016-03-30 06:26:00-04:00,DGX,neutral
357635.0,Quest Diagnostics Prices Up To $200M Combined Aggregate Notes,2016-03-28 15:37:00-04:00,DGX,neutral
357636.0,"Credit Suisse Assumes Quest Diagnostics at Neutral, Announces $72.00 PT",2016-03-15 16:16:00-04:00,DGX,positive
357637.0,DermTech Launches Partnership with Dermpath Diagnostics,2016-03-02 10:30:00-05:00,DGX,neutral
357638.0,"Mizuho Securities Upgrades Quest Diagnostics to Buy, Raises to $75.00",2016-03-01 04:17:00-05:00,DGX,positive
357639.0,"Quest Diagnostics Sees FY 2016 EPS $5.02 to $5.17 vs $5.09 est, Revenue $7.52B to $7.59B vs $7.58B est",2016-01-28 06:48:00-05:00,DGX,neutral
357640.0,"Quest Diagnostics Q4 EPS $1.19 vs $1.19 est, Revenue $1.85B vs $1.85B est",2016-01-28 06:47:00-05:00,DGX,neutral
357641.0,"Earnings Scheduled For January 28, 2016",2016-01-28 04:04:00-05:00,DGX,neutral
357642.0,Quest Diagnostics Increases Buyback by $500M,2015-12-04 06:58:00-05:00,DGX,neutral
357643.0,Quest Diagnostics Spikes Higher,2015-10-23 13:33:00-04:00,DGX,neutral
357644.0,"Quest Diagnostics Reports Q3 Adj EPS $1.28 Vs Est $1.26, Sales $1.88B Vs Est $1.89B; Sees FY Adj EPS $4.75-$4.80 Vs Est $4.76",2015-10-22 06:46:00-04:00,DGX,neutral
357645.0,"Earnings Scheduled For October 22, 2015",2015-10-22 05:00:00-04:00,DGX,neutral
357646.0,Quest Diagnostics' ExamOne Life Insurance Testing Business to Acquire Superior Mobile Medics,2015-10-21 16:18:00-04:00,DGX,positive
357647.0,Quest Unit Focus Says FDA Clears Simplexa Flu A/B; RSV Direct Test to Include 53 New Virus Strains for  2015-2016 Flu Season,2015-10-06 12:29:00-04:00,DGX,negative
357648.0,14 Healthcare Stocks Fundstrat Is Buying,2015-10-05 11:39:00-04:00,DGX,neutral
357649.0,"Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer",2015-10-02 15:40:00-04:00,DGX,negative
357650.0,"Quest Diagnostics, Inovalon Advance Value Healthcare With Industry-First Real-Time Analytics At Point Of Care",2015-09-29 07:02:00-04:00,DGX,positive
357651.0,"CardioDx Expands Patient Access to the Corus CAD Test Through National Agreement With Quest Diagnostics, Raises $20M In New Financing",2015-09-16 08:31:00-04:00,DGX,positive
357652.0,Focus Diagnostics Receives FDA Clearance to Add Genital Swab Claim to Moderate Complexity Simplexa™ HSV 1 & 2 Direct Molecular Test,2015-09-03 10:58:00-04:00,DGX,neutral
357653.0,Fast Money Picks For July 28,2015-07-28 06:47:00-04:00,DGX,neutral
357654.0,Quest Diagnostics Increases 2%-3% FY15 Rev. Between $7.49B-7.57B vs. Est. $7.59B; Adj. EPS $4.70-$4.85 vs. Est. $4.73,2015-07-23 07:26:00-04:00,DGX,neutral
357655.0,"Quest Diagnostics Reports Q2 EPS $1.25 Vs Est $1.23, Sales $1.93B Vs Est $1.93B",2015-07-23 07:04:00-04:00,DGX,neutral
357656.0,"Earnings Scheduled For July 23, 2015",2015-07-23 04:46:00-04:00,DGX,neutral
357657.0,Quest Diagnostics to Acquire MemorialCare Health System's Laboratory Outreach Service Business,2015-06-30 19:45:00-04:00,DGX,positive
357658.0,MKM Looked To The Options Market To Find Its Top 10 M&A Targets,2015-06-23 14:05:00-04:00,DGX,positive
357659.0,Benzinga's Top Downgrades,2015-06-23 10:10:00-04:00,DGX,positive
357660.0,Goldman Sachs Downgrades Quest Diagnostics to Neutral,2015-06-23 06:32:00-04:00,DGX,neutral
357661.0,Benzinga's Top Initiations,2015-06-16 09:19:00-04:00,DGX,positive
357662.0,KeyBanc Initiates Quest Diagnostics With Sector Weight,2015-06-16 08:28:00-04:00,DGX,neutral
357663.0,KeyBanc Initiates Coverage on Quest Diagnostics at Sector Weight,2015-06-16 06:41:00-04:00,DGX,neutral
357664.0,Quest Diagnostics Announces Will Comment on '15 Sales Guidance (Amid JV Progress) at Goldman's 36th Annual Global Healthcare Conference,2015-06-09 08:07:00-04:00,DGX,neutral
357665.0,Jefferies Bullish On Home Health; Points Out Positives For 19 Stocks,2015-06-05 16:25:00-04:00,DGX,positive
357666.0,Quest Diagnostics: What The Heck Is Happening?,2015-05-22 12:24:00-04:00,DGX,neutral
357667.0,Quest Diagnostic Spokesperson Declines Comment on Share Price Move,2015-05-22 12:12:00-04:00,DGX,positive
357668.0,"RBC Analyst On Potential Sale By Goldman Sachs, ""DGX's Spike Is Probably Just A Rumor, Things Like This Happen All The Time""",2015-05-22 11:49:00-04:00,DGX,positive
357669.0,Tara Lachapelle Bloomberg @taralach  · Tweet:  is this $dgx and $lh stuff just an avon sequel...,2015-05-22 10:47:00-04:00,DGX,neutral
357670.0,"Following Volatility Halt and Goldman Sachs Sale Exploration Rumor, Quest Diagnostics Spikes Up 16% To Around ~$86",2015-05-22 10:42:00-04:00,DGX,positive
357671.0,Quest Diagnostics Trading Resumed,2015-05-22 10:39:00-04:00,DGX,neutral
357672.0,Quest Diagnostics Trading Halted; Volatility Pause,2015-05-22 10:34:00-04:00,DGX,neutral
357673.0,Hearing Unconfirmed Market Chatter Quest Diagnostics has Hired Goldman Sachs to Explore Sale,2015-05-22 10:16:00-04:00,DGX,negative
357674.0,"Quest Diagnostics Reports Q1 Adj. EPS $1.05 vs $1.04 Est., Sales $1.84B, Inline; Reaffirms FY EPS Outlook of $4.70-$4.85 vs $4.78 Est.",2015-04-23 07:10:00-04:00,DGX,neutral
357675.0,"Earnings Scheduled For April 23, 2015",2015-04-23 04:03:00-04:00,DGX,neutral
357676.0,Focus Diagnostics Announces FDA Clears Simplexa Group A Strep Direct Test,2015-04-15 12:32:00-04:00,DGX,positive
357677.0,US Stock Futures Slide Ahead Of Economic Data,2015-03-31 07:40:00-04:00,DGX,neutral
357678.0,Quintiles Quest Diagnostics to Form JV to Provide Global Clinical Trials Laboratory Services,2015-03-31 06:03:00-04:00,DGX,neutral
357679.0,JMP Securities Initiates Coverage on Quest Diagnostics at Market Perform,2015-03-27 06:43:00-04:00,DGX,positive
357680.0,"Deutsche Bank Is Downgrading Quest Diagnostics, But Notes 4 Key Upside Catalysts",2015-03-25 09:37:00-04:00,DGX,neutral
357681.0,Deutsche Bank Downgrades Quest Diagnostics To Hold,2015-03-25 09:06:00-04:00,DGX,neutral
357682.0,Benzinga's Top Downgrades,2015-03-25 09:02:00-04:00,DGX,positive
357683.0,"Deutsche Bank Downgrades Quest Diagnostics to Hold, Raises  PT to $80.00",2015-03-25 05:56:00-04:00,DGX,neutral
357684.0,Stocks Hitting 52-Week Highs,2015-03-18 10:08:00-04:00,DGX,neutral
357685.0,Morning Market Gainers,2015-03-18 09:43:00-04:00,DGX,neutral
357686.0,"Vermillion Says on March 11, 2015 Co, Unit Entered Into Three Agreements With Quest Diagnostics",2015-03-17 16:14:00-04:00,DGX,positive
357687.0,Quest Diagnostics Announces Availability of Neurome To Diagnose  Pediatric Neurological Disorders,2015-03-10 08:37:00-04:00,DGX,neutral
357688.0,Quest Diagnostics Announces $1.2B Senior Note Offering,2015-03-05 08:22:00-05:00,DGX,neutral
357689.0,"Canaccord Genuity Upgrades Quest Diagnostics to Buy, Raises PT to $82.00",2015-03-03 06:35:00-05:00,DGX,neutral
357690.0,Benzinga's Top Initiations,2015-03-02 09:59:00-05:00,DGX,positive
357691.0,Barclays Initiates Quest Diagnostics With Equalweight,2015-03-02 09:37:00-05:00,DGX,neutral
357692.0,"Barclays Initiates Coverage on Quest Diagnostics at Equalweight, Announces $78.00 PT",2015-03-02 06:59:00-05:00,DGX,neutral
357693.0,Bank of America Downgrades Quest Diagnostics To  Underperform,2015-02-23 08:55:00-05:00,DGX,neutral
357694.0,Benzinga's Top Downgrades,2015-02-23 08:36:00-05:00,DGX,positive
357695.0,Bank of America Downgrades Quest Diagnostics to Underperform,2015-02-23 06:22:00-05:00,DGX,neutral
357696.0,"Quest Diagnostics, Myriad Genetics Dismiss BRCA Gene Patent Litigation",2015-02-09 08:47:00-05:00,DGX,negative
357697.0,Benzinga's Top Downgrades,2015-01-30 09:15:00-05:00,DGX,positive
357698.0,Wells Fargo Downgrades Quest Diagnostics To  Underperform,2015-01-30 07:58:00-05:00,DGX,positive
357699.0,Wells Fargo Downgrades Quest Diagnostics to Underperform,2015-01-30 06:18:00-05:00,DGX,positive
357700.0,Wells Fargo Downgrades Quest Diagnostics to Underperform,2015-01-30 05:58:00-05:00,DGX,positive
357701.0,"Earnings Scheduled For January 29, 2015",2015-01-29 04:45:00-05:00,DGX,neutral
357702.0,"Morgan Stanley Previews Earnings For Cardinal Health, Quest Diagnostics",2015-01-28 12:05:00-05:00,DGX,neutral
357703.0,"Quest Diagnostics, CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and Treatment",2015-01-28 11:01:00-05:00,DGX,positive
357704.0,Oppenheimer Sees Upside Surprise This Earnings Season,2015-01-15 10:04:00-05:00,DGX,positive
357705.0,From Goldman Sachs Conference: Quest Diagnostics Sees 1-2% Growth From M&A; Plans Smaller Tuck Acquisitions; Sees Revenue Up 2-5% Over Next 3 Years,2015-01-06 11:37:00-05:00,DGX,positive
357706.0,Stocks Hitting 52-Week Highs,2015-01-02 10:18:00-05:00,DGX,neutral
357707.0,Morning Market Movers,2015-01-02 09:39:00-05:00,DGX,neutral
357708.0,Raymond James Upgrades Quest Diagnostics to Market Perform,2015-01-02 05:46:00-05:00,DGX,neutral
357709.0,"Bank of America Maintains Neutral on Quest Diagnostics, Raises PT to $68.00",2014-12-29 04:12:00-05:00,DGX,neutral
357710.0,"S&P 500 Stocks With Most Active Options Today: NWL, HST, EA, MET, DGX",2014-12-23 15:18:00-05:00,DGX,positive
357711.0,Deutsche Bank Offers Up A Pair Trade Idea On Quest Diagnostics & Laboratory Corp. of America,2014-11-13 10:13:00-05:00,DGX,neutral
357712.0,Benzinga's Top Upgrades,2014-11-13 09:19:00-05:00,DGX,positive
357713.0,Deutsche Bank Upgrades Quest Diagnostics To Buy,2014-11-13 08:51:00-05:00,DGX,neutral
357714.0,"Deutsche Bank Upgrades Quest Diagnostics Incorporated to Buy, Raises PT to $75.00",2014-11-13 06:45:00-05:00,DGX,neutral
357715.0,"Quest Diagnostics Outlines Progress in Executing Strategy to Drive Holder Value: Expecting FY Adj. EPS Growth in 8-10% Range (On Average) Over Next Three Years, Sales Growth 2-5%",2014-11-05 08:04:00-05:00,DGX,positive
357716.0,Quest Diagnostics Incorporated Reports Q3 EPS of $1.10 vs $1.08 Est; Revenue of $1.90B vs $1.87B Est,2014-10-23 07:05:00-04:00,DGX,neutral
357717.0,"Earnings Scheduled For October 23, 2014",2014-10-23 05:11:00-04:00,DGX,neutral
357718.0,Quest Diagnostics Added To Goldman Sachs Conviction Buy List,2014-09-03 08:41:00-04:00,DGX,neutral
357719.0,Shares of Quest Diagnostics Quiet Premarket Despite Being Added to Goldman's 'Conviction Buy' List,2014-09-03 07:51:00-04:00,DGX,positive
357720.0,Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest Dividend Yield,2014-09-02 05:00:00-04:00,DGX,positive
357721.0,Quest Diagnostics Incorporated Narrows FY2014 EPS Guidance from $3.95-4.15 to $4.00-4.10 vs $4.02 Est,2014-07-24 07:12:00-04:00,DGX,neutral
357722.0,Quest Diagnostics Incorporated Reports Q2 EPS of $1.08 vs $1.06 Est; Revenue of $1.90B vs $1.88B Est,2014-07-24 07:05:00-04:00,DGX,neutral
357723.0,"Earnings Scheduled For July 24, 2014",2014-07-24 05:31:00-04:00,DGX,neutral
357724.0,"Mid-Day Market Movers For Monday, June 16, 2014",2014-06-16 12:52:00-04:00,DGX,neutral
357725.0,Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th,2014-06-10 11:04:00-04:00,DGX,neutral
357726.0,"Option Alert: Quest Diagnostics Nov $65 Call; 12,936 Contracts Traded vs 1,493 OI; Currently $60.43",2014-06-03 11:19:00-04:00,DGX,positive
357727.0,"Memorial Sloan Kettering Cancer Center, Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment ",2014-06-01 10:01:00-04:00,DGX,negative
357728.0,UPDATE: Bank Of America Upgrades Quest Diagnostics On Near-Term Outlook,2014-05-08 09:12:00-04:00,DGX,neutral
357729.0,Benzinga's Top Upgrades,2014-05-08 07:52:00-04:00,DGX,positive
357730.0,"Bank of America Upgrades Quest Diagnostics Incorporated to Neutral, Raises PO to $58.00",2014-05-08 07:16:00-04:00,DGX,negative
357731.0,"Bank of America Upgrades Quest Diagnostics Incorporated to Neutral, Raises PO to $58.00",2014-05-08 06:52:00-04:00,DGX,negative
357732.0,Quest Diagnostics Incorporated Sees FY2014 EPS $3.95-4.15 vs $4.04 Est,2014-04-24 07:07:00-04:00,DGX,neutral
357733.0,Quest Diagnostics Incorporated Reports Q1 EPS of $0.84 vs $0.89 Est; Revenue of $1.75B vs $1.75B Est,2014-04-24 07:06:00-04:00,DGX,neutral
357734.0,"Earnings Scheduled For April 24, 2014",2014-04-24 05:33:00-04:00,DGX,neutral
357735.0,Quest Diagnostics Extends Partnership with Steward Health Care System,2014-04-23 16:50:00-04:00,DGX,positive
357736.0,US Stock Futures Edge Lower Ahead Of Wholesale Trade Data,2014-03-11 07:19:00-04:00,DGX,negative
357737.0,Quest Diagnostics to Acquire Summit Health; Terms Not Disclosed,2014-03-11 07:01:00-04:00,DGX,neutral
357738.0,Quest Diagnostics Sees FY2014 EPS $3.95-4.15 vs $4.33 Est,2014-03-10 07:13:00-04:00,DGX,neutral
357739.0,Quest Diagnostics Sees Full Year 2014 Revenues Expected to Grow 2%-4% vs 2013,2014-03-10 07:02:00-04:00,DGX,neutral
357740.0,Quest Diagnostics Exec Speaking at RBC Capital Healthcare Conference: Says Weather Had Impact on Business,2014-02-25 08:35:00-05:00,DGX,neutral
357741.0,Stocks Hitting 52-Week Lows,2014-02-04 10:17:00-05:00,DGX,negative
357742.0,"Morgan Stanley Maintains Underweight on Quest Diagnostics Incorporated, Lowers PT to $51.00",2014-01-31 07:49:00-05:00,DGX,negative
357743.0,"UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 Forecast",2014-01-30 08:48:00-05:00,DGX,positive
357744.0,"Earnings Scheduled For January 30, 2014",2014-01-30 04:54:00-05:00,DGX,neutral
357745.0,"Maxim Group Assumes Quest Diagnostics Incorporated at Buy, Announces $68.00 PT",2014-01-28 08:25:00-05:00,DGX,neutral
357746.0,"Quest Diagnostics to Purchase Solstas Lab Partners from Welsh, Carson, Anderson-Stowe for $570M, Sees Deal Adding 'Modesty' to Adj. EPS in 2014",2014-01-22 08:30:00-05:00,DGX,neutral
357747.0,Quest Diagnostics Adds Timothy L. Main to Board of Directors,2014-01-13 16:53:00-05:00,DGX,neutral
357748.0,"UC San Francisco, Quest Diagnostics Form Collaboration",2014-01-09 11:05:00-05:00,DGX,neutral
357749.0,Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostic,2014-01-09 05:36:00-05:00,DGX,neutral
357750.0,"Quest Diagnostics, University to Develop Diagnostic Tools",2014-01-08 14:28:00-05:00,DGX,neutral
357751.0,UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple Industry Headwinds,2013-12-18 09:42:00-05:00,DGX,positive
357752.0,JMP Securities Initiates Coverage on Quest Diagnostics Incorporated at Market Perform,2013-12-18 06:54:00-05:00,DGX,positive
357753.0,Quest Diagnostics Incorporated Raises FY2013 EPS Guidance from $3.85-3.95 to $3.90-3.95 vs $3.90 Est,2013-12-12 17:38:00-05:00,DGX,neutral
357754.0,UPDATE: Morgan Stanley Removes PT on Quest Diagnostics on Model Update Ahead of Challenging 2014,2013-12-12 08:58:00-05:00,DGX,positive
357755.0,"UPDATE: Citigroup Lowers PT on Quest Diagnostics, Two Shots are Enough",2013-12-11 13:54:00-05:00,DGX,negative
357756.0,UPDATE: Bank of America Downgrades Quest Diagnostics on Reduced 2014 EPS Estimate,2013-12-10 10:42:00-05:00,DGX,neutral
357757.0,Benzinga's Top Downgrades,2013-12-10 08:04:00-05:00,DGX,positive
357758.0,US Stock Futures Up Ahead Of Wholesale Trade Data,2013-12-10 06:59:00-05:00,DGX,neutral
357759.0,"Bank of America Downgrades Quest Diagnostics Incorporated to Underperform, Lowers PO to $55.00",2013-12-10 06:29:00-05:00,DGX,negative
357760.0,Benzinga's Top Initiations,2013-11-19 08:08:00-05:00,DGX,positive
357761.0,"ISI Group Initiates Coverage on Quest Diagnostics Incorporated at Neutral, Announces $63.00 PT",2013-11-19 07:49:00-05:00,DGX,neutral
357762.0,Collabrx Rises 70% Pre-Market on Deal with Quest Diagnostics on Clinical Genetic Sequencing,2013-11-11 08:29:00-05:00,DGX,neutral
357763.0,Quest Diagnostics Incorporated Lowers FY2013 EPS Guidance from $4.35-4.50 to $3.85-3.95 vs $4.05 Est,2013-10-17 07:07:00-04:00,DGX,negative
357764.0,Quest Diagnostics Incorporated Reports Q3 EPS of $1.02 vs $1.20 Est; Revenue of $1.79B vs $1.84B Est,2013-10-17 07:01:00-04:00,DGX,neutral
357765.0,"Earnings Scheduled For October 17, 2013",2013-10-17 04:43:00-04:00,DGX,neutral
357766.0,UPDATE: Citigroup Lowers PT on Quest Diagnostics Following Disappointing 3Q13 Results,2013-10-11 11:34:00-04:00,DGX,negative
357767.0,Disappointing Preliminary Earnings from Quest Diagnostics Trickles Down to Qiagen,2013-10-10 14:23:00-04:00,DGX,negative
357768.0,Quest Diagnostics Incorporated Reports Prelim. Q3 EPS of $1.02 vs $1.20 Est; Revenue of $1.79B vs $1.84B Est,2013-10-10 06:46:00-04:00,DGX,neutral
357769.0,Quest Acquires ConVerge Diagnostic Services ,2013-10-07 19:49:00-04:00,DGX,neutral
357770.0,"Quest Diagnostics Closes Sale of Enterix Unit, Expecting Loss of $0.17/Share, Gain of $1.96/Share Related to Sale of Ibrutinib Royalty Rights",2013-10-01 16:53:00-04:00,DGX,positive
357771.0,"Craig-Hallum Initiates Coverage on Quest Diagnostics Incorporated at Buy, Announces $74.00 PT",2013-09-19 09:32:00-04:00,DGX,neutral
357772.0,"Quest Diagnostics Reports Accelerated Buyback Plan, Will Buyback ~$350M",2013-09-05 07:47:00-04:00,DGX,neutral
357773.0,"Quest Diagnostics Adds $1B to Buyback Plan, Now Totals $1.3B",2013-08-20 16:35:00-04:00,DGX,neutral
357774.0,Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent Ibrutinib Royalty Purchase ,2013-08-12 07:03:00-04:00,DGX,neutral
357775.0,"FDA Approves First Rapid Diagnostic Test to Detect Both HIV-1 Antigen, HIV-1/2",2013-08-08 14:30:00-04:00,DGX,positive
357776.0,"Maxim Group Upgrades Quest Diagnostics Incorporated to Buy, Announces $73.00 PT",2013-08-08 08:37:00-04:00,DGX,neutral
357777.0,  Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Lowest PEG Ratio,2013-07-30 04:18:00-04:00,DGX,negative
357778.0,A Peek Into The Market Before The Trading Starts,2013-07-18 07:31:00-04:00,DGX,neutral
357779.0,Quest Diagnostics Incorporated Narrows FY2013 EPS Guidance from $4.35-4.55 to $4.35-4.50 vs $4.34 Est,2013-07-18 07:04:00-04:00,DGX,neutral
357780.0,Quest Diagnostics Incorporated Reports Q2 EPS of $1.06 vs $1.09 Est; Revenue of $1.82B vs $1.84B Est,2013-07-18 07:04:00-04:00,DGX,neutral
357781.0,Quest Diagnostics Sells Ibrutinib Royalty Rights to Royalty Pharma For $485M in Cash,2013-07-18 06:54:00-04:00,DGX,neutral
357782.0,Quest Diagnostics Names Mark J. Guinan as New CFO ,2013-07-17 17:00:00-04:00,DGX,neutral
357783.0,"Baird Initiates Coverage on Quest Diagnostics Incorporated at Neutral, Announces $58.00 PT",2013-07-12 07:42:00-04:00,DGX,neutral
357784.0,UPDATE: Morgan Stanley Downgrades Quest Diagnostics on Reimbursement Environment,2013-07-09 09:09:00-04:00,DGX,neutral
357785.0,Benzinga's Top Downgrades,2013-07-09 08:29:00-04:00,DGX,positive
357786.0,"Morgan Stanley Downgrades Quest Diagnostics Incorporated to Underweight, Announces $58.00 PT",2013-07-09 08:08:00-04:00,DGX,neutral
357787.0,"Morgan Stanley Downgrades Quest Diagnostics Incorporated to Underweight, Announces $58.00 PT",2013-07-09 07:41:00-04:00,DGX,neutral
357788.0,Myriad Ruling Causes 15 Percent Swing Thursday – Here's Why,2013-06-14 08:03:00-04:00,DGX,neutral
357789.0,"DJ Reporting Quest Diagnostics to Offer BRCA1, BRCA2 Test Later This Year",2013-06-13 15:35:00-04:00,DGX,neutral
357790.0,Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference,2013-06-06 16:02:00-04:00,DGX,neutral
357791.0,Hologic Shares Turn Positive Following News of Alliance with Quest Diagnosstics,2013-06-06 13:25:00-04:00,DGX,positive
357792.0,Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Profit Margin,2013-06-03 04:09:00-04:00,DGX,positive
357793.0,"Quest Diagnostics Buys Concentra's Lab Unit, Expects Deal to Be Accretive to 2013 Adj. EPS",2013-05-16 10:13:00-04:00,DGX,neutral
357794.0,NY AG Announces Settlement with Quest Diagnostics,2013-05-09 12:24:00-04:00,DGX,neutral
357795.0,"From Weight Watchers  Quest , 'Quota Share', to Catastrophe Bonds Were Still Finding Value",2013-05-06 10:03:00-04:00,DGX,negative
357796.0,Form 8-K Shows Quest Diagnostics Entered Into Accelerated Buyback Plan for $450M,2013-04-23 07:55:00-04:00,DGX,neutral
357797.0,A Peek Into The Market Before The Trading Starts,2013-04-17 07:47:00-04:00,DGX,neutral
357798.0,UPDATE: Quest Q1 Profit Drops 15%,2013-04-17 07:38:00-04:00,DGX,positive
357799.0,"UPDATE: Quest Diagnostics Sees FY13 Sales About Same as 2012, Had Seen Flat to 1% Growth",2013-04-17 07:20:00-04:00,DGX,positive
357800.0,Quest Diagnostics Incorporated Reports Q1 EPS of $0.89 vs $1.03 Est; Revenue of $1.79B vs $1.86B Est,2013-04-17 07:05:00-04:00,DGX,neutral
357801.0,US Stock Futures Down; Bank of America Earnings In Focus,2013-04-17 06:49:00-04:00,DGX,neutral
357802.0,Quest Diagnostics Agrees to Acquire Lab-Related Clinical Outreach Operations of Dignity Health ,2013-04-17 06:39:00-04:00,DGX,positive
357803.0,"Earnings Scheduled For April 17, 2013",2013-04-17 05:24:00-04:00,DGX,neutral
357804.0,UPDATE: Goldman Sachs Upgrades Quest Diagnostics to Buy on Improved Fundamentals,2013-04-11 09:51:00-04:00,DGX,positive
357805.0,Benzinga's Top Pre-Market Gainers ,2013-04-11 07:33:00-04:00,DGX,positive
357806.0,Benzinga's Top Upgrades,2013-04-11 06:37:00-04:00,DGX,positive
357807.0,"Goldman Sachs Upgrades Quest Diagnostics Incorporated to Buy, Raises PT to $67.00",2013-04-11 06:24:00-04:00,DGX,neutral
357808.0,Quest Diagnostics Names Sukumar Nagendran as VP of Medical Affairs,2013-04-02 10:51:00-04:00,DGX,neutral
357809.0,"Quest Diagnostics Searching for New CFO, Current CFO Robert A. Hagemann Leaving End of May",2013-03-14 07:16:00-04:00,DGX,neutral
357810.0,A Peek Into The Market Before The Trading Starts,2013-02-25 07:13:00-05:00,DGX,neutral
357811.0,Quest Diagnostics Announces Sale of  HemoCue Business to Radiometer Medical ApS for $300M,2013-02-25 06:03:00-05:00,DGX,neutral
357812.0,"UPDATE: Oppenheimer Initiates Quest Diagnostics at Underperform on Restructuring, Industry Risks",2013-01-29 07:35:00-05:00,DGX,negative
357813.0,"Oppenheimer Initiates Coverage on Quest Diagnostics Incorporated at Underperform, Announces $53.00 undefined",2013-01-28 16:13:00-05:00,DGX,neutral
357814.0,"JP Morgan Maintains Neutral on Quest Diagnostics Incorporated, Lowers PT to $58.00",2013-01-23 13:06:00-05:00,DGX,positive
357815.0,Quest Diagnostics Incorporated Reports Q4 EPS of $1.01 vs $1.08 Est; Revenue of $1.77B vs $1.80B Est,2013-01-23 07:19:00-05:00,DGX,neutral
357816.0,"Benzinga Market Primer: Wednesday, January 23",2013-01-23 06:29:00-05:00,DGX,neutral
357817.0,"Earnings Scheduled For January 23, 2013",2013-01-23 02:42:00-05:00,DGX,neutral
357818.0,Quest Diagnostics to Sell HemoCue Diagnostic Products Business,2013-01-16 07:17:00-05:00,DGX,neutral
357819.0,"Bank of America Merrill Lynch Reiterates Buy Rating, $64 PT on Quest Diagnostics",2013-01-02 12:53:00-05:00,DGX,neutral
357820.0,Quest Diagnostics Buys UMass Memorial Medical Center's Outreach Lab Business,2013-01-02 08:54:00-05:00,DGX,positive
357821.0,Macquarie Upgraded Quest Diagnostics from Underperform to Neutral,2012-11-20 09:41:00-05:00,DGX,neutral
357822.0,"From Earlier: Quest Diagnostics Reaffirms Outlook, Raises Qtr. Dividend from $0.17 to $0.30/Share",2012-11-16 09:26:00-05:00,DGX,neutral
357823.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Quest Diagnostics",2012-11-05 09:59:00-05:00,DGX,negative
357824.0,"Jefferies & Company Maintains Quest Diagnostics at Hold, Lowers PT from $63 to $59",2012-11-05 07:55:00-05:00,DGX,negative
357825.0,Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Lowest PEG Ratio,2012-11-02 03:00:00-04:00,DGX,negative
357826.0,Earnings Analysis: Quest Diagnostics Inc,2012-10-19 10:14:00-04:00,DGX,neutral
357827.0,"UBS Maintains Quest Diagnostics at Neutral, Raises PT from $61 to $62",2012-10-18 14:08:00-04:00,DGX,neutral
357828.0,"Goldman Sachs Maintains Quest Diagnostics at Neutral, Lowers PT from $61 to $60",2012-10-17 14:26:00-04:00,DGX,negative
357829.0,UPDATE: Canaccord Genuity Reduces PT to $59 on Quest Diagnostics   ,2012-10-17 14:06:00-04:00,DGX,neutral
357830.0,"Canaccord Maintains Quest Diagnostics at Hold, Lowers PT from $60 to $59",2012-10-17 12:03:00-04:00,DGX,negative
357831.0,FROM EARLIER: Quest Diagnostics Reports Q3 EPS $1.18 vs $1.18 Est; Revenues $1.85B vs $1.91B Est,2012-10-17 07:37:00-04:00,DGX,neutral
357832.0,"Benzinga Market Primer, Wednesday October 17",2012-10-17 06:09:00-04:00,DGX,neutral
357833.0,US Stock Futures Flat; Bank of America Earnings In Focus,2012-10-17 06:00:00-04:00,DGX,neutral
357834.0,"Earnings Scheduled For October 17, 2012",2012-10-17 03:14:00-04:00,DGX,neutral
357835.0,Quest Sees Deal Neutral to EPS in FY12; Adding to EPS in FY13,2012-10-16 16:38:00-04:00,DGX,neutral
357836.0,Quest Diagnostics Says Will Cut 400-600 Management Jobs; Create 2 New Business Structures,2012-10-11 09:03:00-04:00,DGX,neutral
357837.0,Augurex Announces Exclusive License Agreement with Quest,2012-10-09 16:03:00-04:00,DGX,positive
357838.0,"Deutsche Bank Maintains Quest Diagnostics at Hold, Raises PT from $65 to $70",2012-10-08 06:57:00-04:00,DGX,neutral
357839.0,"UPDATE: Credit Suisse Assumes Coverage on Quest Diagnostics with Neutral Rating, $67 PT",2012-09-14 13:58:00-04:00,DGX,positive
357840.0,Benzinga's Top Downgrades,2012-09-14 07:32:00-04:00,DGX,positive
357841.0,"Credit Suisse Downgrades Quest Diagnostics from Outperform to Neutral, Announces PT of $67",2012-09-14 06:17:00-04:00,DGX,positive
357842.0,"Jefferies & Company Maintains Quest Diagnostics at Hold, Lowers PT from $66 to $63",2012-08-09 06:40:00-04:00,DGX,negative
357843.0,"Jefferies & Company Maintains Quest Diagnostics at Hold, Lowers PT from $66 to $63",2012-08-09 06:36:00-04:00,DGX,negative
357844.0,"UPDATE: Credit Suisse Reiterates Outperform Rating, Lowers PT on Quest Diagnostics",2012-07-20 12:00:00-04:00,DGX,positive
357845.0,"Credit Suisse Maintains Quest Diagnostics at Outperform, Lowers PT from $68 to $67",2012-07-20 06:17:00-04:00,DGX,positive
357846.0,"Deutsche Bank Maintains Quest Diagnostics at Hold, Lowers PT from $68 to $65",2012-07-19 13:40:00-04:00,DGX,negative
357847.0,UPDATE: Quest Diagnostics Q2 Profit Up 9%,2012-07-19 07:58:00-04:00,DGX,positive
357848.0,Earnings Scheduled For July 19,2012-07-19 02:56:00-04:00,DGX,neutral
357849.0,"Social Media Outlook, Friday July 13",2012-07-13 12:24:00-04:00,DGX,neutral
357850.0,"Deutsche Bank Maintains Quest Diagnostics at Hold, Raises PT from $66 to $68",2012-07-12 15:35:00-04:00,DGX,neutral
357851.0,"Quest Diagnostics Hits 52-Week High Earlier, Company Spokesperson Says No Company Generated News to Account for Move",2012-07-12 11:48:00-04:00,DGX,negative
357852.0,"Quest Diagnostics Rises 4% to New 52-Week High, $63.19",2012-07-12 11:28:00-04:00,DGX,neutral
357853.0,"UPDATE: Goldman Sachs Upgrades Quest Diagnostics to Neutral on Defensiveness, New CEO  ",2012-07-02 10:38:00-04:00,DGX,negative
357854.0,Goldman Sachs Upgrades Quest Diagnostics from Sell to Neutral,2012-07-02 08:22:00-04:00,DGX,neutral
357855.0,Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROA,2012-06-29 02:05:00-04:00,DGX,positive
357856.0,"UPDATE: Canaccord Genuity Initiates Quest Diagnostics with Hold, $60 PT; No Immediate Catalysts  ",2012-06-21 07:27:00-04:00,DGX,negative
357857.0,"Canaccord Initiates Coverage On Quest Diagnostics at Hold, Announces PT of $60",2012-06-21 05:47:00-04:00,DGX,neutral
357858.0,Benzinga's Top Downgrades,2012-06-06 07:27:00-04:00,DGX,positive
357859.0,Credit Suisse Focus List 5/30/2012,2012-06-01 14:24:00-04:00,DGX,positive
357860.0,"Bank of America Maintains Quest Diagnostics at Buy, Raises PO from $60 to $61",2012-04-18 12:03:00-04:00,DGX,negative
357861.0,"Morning Social Media Outlook for Friday April 18 (SRSL, DGX, ACI, WFC)",2012-04-18 10:08:00-04:00,DGX,neutral
357862.0,Quest Diagnostics Reports Q1 EPS $1.07 vs $1.01 Est; Revenues $1.9B vs $1.88B Est,2012-04-18 07:01:00-04:00,DGX,neutral
357863.0,Citi: Quest Diagnostics Announces New CEO,2012-04-12 07:31:00-04:00,DGX,neutral
357864.0,Quest Diagnostics Appoints Stephen Rusckowski As CEO,2012-04-12 04:45:00-04:00,DGX,neutral
357865.0,Quest Diagnostics Names Steve Rusckowski as President and CEO ,2012-04-11 16:19:00-04:00,DGX,neutral
357866.0,FDA Clears the Quest Diagnostics Simplexa C. difficile Molecular Test ,2012-04-11 12:11:00-04:00,DGX,positive
357867.0,Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection ,2012-03-15 13:43:00-04:00,DGX,negative
357868.0,Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Cash,2012-03-13 04:50:00-04:00,DGX,positive
357869.0,Notable Put Options Activity in Quest Diagnostics,2012-02-15 10:36:00-05:00,DGX,neutral
357870.0,Quest Diagnostics Hits 52-Week High of $61.22,2012-01-25 13:28:00-05:00,DGX,neutral
357871.0,UPDATE: Citigroup Raises Target on Quest Diagnostics to $62,2012-01-25 09:58:00-05:00,DGX,neutral
357872.0,"UPDATE: Credit Suisse Raises Target on Quest Diagnostics to $68, Maintains Outperform",2012-01-25 07:22:00-05:00,DGX,positive
357873.0,Citigroup Raises PT on Quest Diagnostics to $63,2012-01-25 06:00:00-05:00,DGX,neutral
357874.0,Hearing Goldman Sachs Cautious on Quest Diagnostics,2012-01-24 13:25:00-05:00,DGX,negative
357875.0,Piper Jaffray Reports Quest Diagnostics Enjoyed a Better-Than-Expected Q4 EPS,2012-01-24 11:06:00-05:00,DGX,positive
357876.0,Earnings Roundup,2012-01-24 10:01:00-05:00,DGX,neutral
357877.0,"Deutsche Bank Maintains Hold, $62 Target on Quest Diagnostics",2012-01-24 09:56:00-05:00,DGX,neutral
357878.0,JP Morgan Maintains Neutral on Quest Diagnostics,2012-01-24 09:42:00-05:00,DGX,positive
357879.0,Benzinga's Top Pre-Market Gainers,2012-01-24 08:14:00-05:00,DGX,positive
357880.0,UPDATE: Quest Diagnostics Reports Rise In Q4 Profit,2012-01-24 08:05:00-05:00,DGX,positive
357881.0,Quest Diagnostics Guides 2012 EPS $4.40-4.55; Rev Growth 2-2.5%,2012-01-24 07:05:00-05:00,DGX,positive
357882.0,Quest Diagnostics Reports Q4 EPS $1.23 vs $1.06 Est; Revenues $1.88B vs $1.86B Est	 		,2012-01-24 07:02:00-05:00,DGX,neutral
357883.0,Quest Diagnostics Increases Share Repurchase Authority by $1 Billion ,2012-01-24 06:46:00-05:00,DGX,positive
357884.0,"End-of-Day Market Summary for January 20, 2012",2012-01-20 16:28:00-05:00,DGX,neutral
357885.0,Quest Diagnostics STRATIFY JCV First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients ,2012-01-20 16:00:00-05:00,DGX,positive
357886.0,S.E.D. Labs to be Acquired by Quest Diagnostics ,2012-01-03 09:30:00-05:00,DGX,neutral
357887.0,S.E.D. Labs to be Acquired by Quest Diagnostics ,2012-01-03 09:16:00-05:00,DGX,neutral
357888.0,"Bank of America Reiterates Buy, $60 Target on Quest Diagnostics ",2011-12-09 07:48:00-05:00,DGX,neutral
357889.0,Jefferies Maintains Hold Rating and $61 PT on Quest Diagnostics ,2011-11-17 07:37:00-05:00,DGX,neutral
357890.0,Quest Diagnostics CE Marks Simplexa Test for Cytomegalovirus for Sale in Europe ,2011-11-15 11:19:00-05:00,DGX,neutral
357891.0,UBS Research PT Changes for 10/26/2011,2011-10-26 10:46:00-04:00,DGX,neutral
357892.0,Goldman Sachs Maintains Sell Rating and $53 PT on Quest Diagnostics ,2011-10-26 09:15:00-04:00,DGX,neutral
357893.0,UPDATE: Credit Suisse Raising Price Target on Quest Diagnostics,2011-10-26 09:00:00-04:00,DGX,positive
357894.0,Goldman Sachs Raises PT on Quest Diagnostics to $53,2011-10-26 07:07:00-04:00,DGX,neutral
357895.0,"End-of-Day Market Summary for October 25, 2011",2011-10-25 16:15:00-04:00,DGX,neutral
357896.0,Top Movers; MF Global Down 47%,2011-10-25 15:56:00-04:00,DGX,positive
357897.0,UPDATE: Standpoint Research Downgrades Quest Diagnostics from Buy to Hold ,2011-10-25 09:40:00-04:00,DGX,neutral
357898.0,Deutsche Bank Maintains Hold Rating and $54 PT on Quest Diagnostics,2011-10-25 08:09:00-04:00,DGX,neutral
357899.0,Quest Diagnostics Reports Q3 EPS $1.08 vs $1.11 Est; Revenues $1.91B vs $1.89B Est,2011-10-25 06:47:00-04:00,DGX,neutral
357900.0,Quest Diagnostics Increases Quarterly Cash Dividend by 70% to $0.17/Share,2011-10-25 06:42:00-04:00,DGX,neutral
357901.0,Quest Diagnostics Initiates CEO Succession Process ,2011-10-25 06:30:00-04:00,DGX,positive
357902.0,Earnings Scheduled For October 25,2011-10-25 04:25:00-04:00,DGX,neutral
357903.0,Quest Diagnostics Spiking Higher on Heavy Volume,2011-10-18 11:00:00-04:00,DGX,neutral
357904.0,"Laboratory Corp. of America Holdings Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-17 10:08:00-04:00,DGX,neutral
357905.0,JP Morgan Maintains Neutral Rating and $57 PT on Quest Diagnostics,2011-10-14 10:20:00-04:00,DGX,positive
357906.0,Piper Jaffray Neutral on Quest Diagnostics ,2011-10-11 07:46:00-04:00,DGX,neutral
357907.0,Benzinga's Top Downgrades,2011-09-23 08:59:00-04:00,DGX,positive
357908.0,"Goldman Sachs Downgrades Quest Diagnostics to Sell, PT Lowered to $48",2011-09-23 07:47:00-04:00,DGX,negative
357909.0,Too Big To Fail Party  09-15-2011,2011-09-15 19:39:00-04:00,DGX,negative
357910.0,Market's Current Built-In Velocity  09-15-2011,2011-09-15 15:18:00-04:00,DGX,neutral
357911.0,UPDATE: Piper Jaffray Lowers PT on Quest Diagnostics to $55,2011-08-25 07:42:00-04:00,DGX,negative
357912.0,Piper Jaffray Lowers PT On Quest Diagnostics To $55,2011-08-25 06:06:00-04:00,DGX,negative
357913.0,Benzinga's Top Upgrades,2011-08-17 07:42:00-04:00,DGX,positive
357914.0,"Goldman Sachs Upgrades Quest Diagnostics To Neutral, $51 PT",2011-08-17 06:13:00-04:00,DGX,neutral
357915.0,Market Rally Led by Consumer Goods and Health Care,2011-08-05 13:54:00-04:00,DGX,positive
357916.0,Benzinga's Top Pre-Market Losers ,2011-07-27 07:50:00-04:00,DGX,negative
357917.0,"Jefferies PT Changes For 7/21, Part 2",2011-07-21 06:41:00-04:00,DGX,neutral
357918.0,Quest Anticipates Q3 Cost Restructuring Charge About $2M,2011-07-20 10:07:00-04:00,DGX,neutral
357919.0,Earnings Roundup ,2011-07-20 09:35:00-04:00,DGX,neutral
357920.0,UPDATE: Quest Diagnostics Reports 16% Decline In Q2 Earnings,2011-07-20 07:54:00-04:00,DGX,neutral
357921.0,Quest Guides 2011 EPS $4.25-4.35 vs. $4.28 Est; Sees 2011 Revenue Up 1.50%,2011-07-20 07:08:00-04:00,DGX,neutral
357922.0,Quest Diagnostics Reports Q2 Cont Ops EPS of $1.02 vs. $1.13 Est; Revenues $1.9B vs. $1.92B Est	,2011-07-20 07:02:00-04:00,DGX,neutral
357923.0,Earnings Scheduled For July 20,2011-07-20 02:59:00-04:00,DGX,neutral
357924.0,Benzinga's Top Downgrades,2011-07-19 07:59:00-04:00,DGX,positive
357925.0,"Jefferies Downgrades DGX, RDNT, SKH, SUNH To Hold",2011-07-19 06:22:00-04:00,DGX,neutral
357926.0,Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROE,2011-07-19 02:45:00-04:00,DGX,positive
357927.0,"Laboratory Corporation of America Holdings Earnings Preview: Analyts Expect Higher Earnings, Revenue from Prior Quarter",2011-07-18 14:55:00-04:00,DGX,neutral
357928.0,Earnings Expectations for the Week of July 18,2011-07-17 09:18:00-04:00,DGX,neutral
357929.0,Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests,2011-07-14 10:46:00-04:00,DGX,positive
357930.0,Deutsche Bank's Healthcare Services PT Changes 7/14,2011-07-14 05:53:00-04:00,DGX,neutral
357931.0,Mad Money Lightning Round: Cramer Likes Southern Company,2011-07-14 02:21:00-04:00,DGX,negative
357932.0,J.P. Morgan Initiates Coverage On Clinical Laboratories With Neutral Rating,2011-07-13 08:36:00-04:00,DGX,neutral
357933.0,Morgan Stanley Reiterates Equal-Weight on Quest Diagnostics,2011-07-13 07:31:00-04:00,DGX,neutral
357934.0,"JP Morgan Initiates Coverage On LH, DGX",2011-07-13 06:39:00-04:00,DGX,positive
357935.0,Tuesday's Put/Call Ratio Leaders,2011-07-12 12:12:00-04:00,DGX,neutral
357936.0,Options Brief: Quest Diagnostics,2011-07-12 10:46:00-04:00,DGX,neutral
357937.0,Hottest and Coldest Sectors for Friday 7/8/11,2011-07-08 17:24:00-04:00,DGX,neutral
357938.0,Stocks to Watch for 6/20/11: Fresh 52-Week Highs and Lows,2011-06-20 04:13:00-04:00,DGX,positive
357939.0,Stocks to Watch for 6/17/11: Fresh 52 Week Highs and Lows,2011-06-17 04:08:00-04:00,DGX,positive
357940.0,Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates,2011-06-17 00:07:00-04:00,DGX,positive
357941.0,Health Care Sector Showing Strength,2011-06-13 13:28:00-04:00,DGX,positive
357942.0,Deutsche Bank Updates,2011-06-02 09:14:00-04:00,DGX,neutral
357943.0,Deutsche Bank Reiterates Hold Rating on Quest Diagnostics ,2011-06-02 07:50:00-04:00,DGX,neutral
357944.0,OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment,2011-05-24 09:22:00-04:00,DGX,negative
357945.0,Top Healthcare and Major Drugs stocks to watch- Sector Performance,2011-05-22 14:55:00-04:00,DGX,positive
357946.0,Quest Diagnostics Finalizes Agreement to Settle California Lawsuit Related to Medi-Cal Billing ,2011-05-19 17:00:00-04:00,DGX,positive
357947.0,"CEOWORLD stock picks that will outperform the S&P 500- BRK-B, SAM, LUK, NYB, SYY, BAX, LVB, RSO, UAN…",2011-05-16 05:35:00-04:00,DGX,neutral
357948.0,"Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Operating Margin (LH, DGX, PPDI, CVD)",2011-05-16 00:42:00-04:00,DGX,positive
357949.0,Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger ,2011-05-11 08:08:00-04:00,DGX,neutral
357950.0,"Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Cash (DGX, PPDI, ALR, CVD)",2011-05-11 02:19:00-04:00,DGX,positive
357951.0,"Jefferies Maintains Rating, PT On DGX",2011-05-10 08:55:00-04:00,DGX,neutral
357952.0,Quest Diagnostics Reaches Agreement in Principle to Settle California Lawsuit Related to Medi-Cal Billing (DGX),2011-05-09 16:16:00-04:00,DGX,positive
357953.0,"Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera, Says 880,139 Celera Shares Tendered (CRA, DGX)",2011-05-09 08:14:00-04:00,DGX,positive
357954.0,"Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera (DGX, CRA)",2011-05-04 08:07:00-04:00,DGX,positive
357955.0,Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today (DGX),2011-05-03 08:08:00-04:00,DGX,neutral
357956.0,A Peek Into The Market Before The Trading Starts,2011-04-20 07:33:00-04:00,DGX,neutral
357957.0,Quest Diagnostics Reports Weaker-Than-Expected Q1 Earnings ,2011-04-20 07:19:00-04:00,DGX,neutral
357958.0,Quest Diagnostics Reports Q1 EPS of $1.00 vs. $1.01; Revenues $1.8B vs. $1.8B,2011-04-20 07:02:00-04:00,DGX,neutral
357959.0,Options Brief: Quest Diagnostics Incorporated (DGX),2011-04-19 10:55:00-04:00,DGX,neutral
357960.0,Quest Diagnostics Extends Tender Offer for all Outstanding Shares of Celera Corporation to May 2,2011-04-18 11:15:00-04:00,DGX,positive
357961.0,Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants,2011-04-18 09:33:00-04:00,DGX,neutral
357962.0,Celera Announces Settlement with Putative Class Action Plaintiffs Regarding Acquisition by Quest Diagnostics ,2011-04-18 09:33:00-04:00,DGX,neutral
357963.0,Quest Diagnostics Announces HSR Clearance for the Acquisition of Celera ,2011-04-13 10:39:00-04:00,DGX,neutral
357964.0,Strong Momentum To Buoy Large Cap Healthcare Says Jefferies,2011-04-04 08:54:00-04:00,DGX,positive
357965.0,Wells Fargo Summary,2011-04-01 08:46:00-04:00,DGX,positive
357966.0,UPDATE: Credit Suisse Upgrades Quest Diagnostics To Outperform,2011-03-29 09:47:00-04:00,DGX,positive
357967.0,Quest Diagnostics Commences Tender Offer for Acquisition of Celera for $8 per Share ,2011-03-28 08:35:00-04:00,DGX,positive
357968.0,Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering ,2011-03-21 08:49:00-04:00,DGX,neutral
357969.0,"Benzinga's Top Pre-Market NASDAQ Gainers (CRA, CIGX, AIXG, JDSU)",2011-03-18 08:09:00-04:00,DGX,positive
357970.0,A Peek Into The Market Before The Trading Starts,2011-03-18 07:37:00-04:00,DGX,neutral
357971.0,Quest Diagnostics to Acquire Celera,2011-03-18 07:01:00-04:00,DGX,neutral
357972.0,Options Brief: Quest Diagnostics Incorporated (DGX),2011-03-07 10:34:00-05:00,DGX,neutral
357973.0,Quest Diagnostics Declares Dividend of $.10,2011-02-16 15:08:00-05:00,DGX,neutral
357974.0,Deutsche Bank Raises The PT On Quest Diagnostics To $64 Following Buyback,2011-02-03 10:12:00-05:00,DGX,neutral
357975.0,Deutsche Bank Raises PT On Quest Diagnostics To $64,2011-02-03 07:31:00-05:00,DGX,neutral
357976.0,Quest Diagnostics Stock Offering by SB Holdings Capital Priced at $56.25 per Share ,2011-02-01 09:12:00-05:00,DGX,positive
357977.0,"Morgan Stanley's Rating Changes (DGX, EM)",2011-01-31 10:43:00-05:00,DGX,neutral
357978.0,"Benzinga's Top Upgrades (DAL, TRI, PLL, DGX)",2011-01-31 08:20:00-05:00,DGX,positive
357979.0,Morgan Stanley Upgrades DGX To Equal Weight,2011-01-31 06:50:00-05:00,DGX,neutral
357980.0,Piper Jaffray Lowers Price Target On Quest Diagnostics Due To Lower Projected Earnings ,2011-01-26 15:54:00-05:00,DGX,negative
357981.0,Piper Jaffray Lowers Price Target On Quest Diagnostics Due To Lower Projected Earnings ,2011-01-26 15:54:00-05:00,DGX,negative
357982.0,Standpoint Research Downgrades Quest Diagnostics to Hold,2011-01-26 13:27:00-05:00,DGX,neutral
357983.0,"Benzinga's Top Upgrades (WDC, BHI, INTC, DGX)",2011-01-26 08:39:00-05:00,DGX,positive
357984.0,RBC Capital Ups DGX To Outperform,2011-01-26 06:36:00-05:00,DGX,neutral
357985.0,"Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates (LH, DGX, CVD, ALR)",2011-01-26 03:36:00-05:00,DGX,positive
357986.0,"Quest Beats, Guides in line  - Analyst Blog",2011-01-25 12:01:00-05:00,DGX,neutral
357987.0,"Quest Beats, Guides in line  - Analyst Blog",2011-01-25 11:45:00-05:00,DGX,neutral
357988.0,Quest Diagnostics Increases Share Repurchase by $750M,2011-01-25 08:39:00-05:00,DGX,positive
357989.0,Earnings Preview: Quest Diagnostics - Analyst Blog,2011-01-24 17:01:00-05:00,DGX,neutral
357990.0,Earnings Preview: Quest Diagnostics - Analyst Blog,2011-01-24 16:34:00-05:00,DGX,neutral
357991.0,Piper Jaffray's Top Picks For Medical Diagnostics,2011-01-14 08:47:00-05:00,DGX,positive
357992.0,Piper Jaffray 	Raises Price Target on Quest Diagnostics (DGX),2010-12-30 09:21:00-05:00,DGX,neutral
357993.0,Piper Jaffray Introduces F2012 Expectations On DGX,2010-12-30 07:50:00-05:00,DGX,neutral
357994.0,Piper Jaffray Raises PT On Quest Diagnostics,2010-12-30 06:58:00-05:00,DGX,neutral
357995.0,Trading Rules in the Quest for Profits,2010-12-28 15:25:00-05:00,DGX,positive
357996.0,Genoptix Up 18% Today (GXDX),2010-12-14 09:33:00-05:00,DGX,neutral
357997.0,"Top 4 Stocks In The Medical Laboratories & Research Industry With The Highest Cash (PPDI, ALR, CVD, DGX)",2010-12-14 05:28:00-05:00,DGX,positive
357998.0,FDA Clears Quest's Simplexa Test - Analyst Blog,2010-12-02 14:30:00-05:00,DGX,positive
357999.0,Quest Diagnostics Declares Dividend of $.10,2010-12-02 14:22:00-05:00,DGX,neutral
358000.0,FDA Clears Quest's Simplexa Test - Analyst Blog,2010-12-02 09:07:00-05:00,DGX,positive
358001.0,Age Discrimination Suit Filed Against Quest Diagnostics Inc,2010-11-29 13:59:00-05:00,DGX,neutral
358002.0,LabCorp Clears Anti-Trust Review - Analyst Blog,2010-11-19 14:33:00-05:00,DGX,positive
358003.0,LabCorp Clears Anti-Trust Review - Analyst Blog,2010-11-19 09:20:00-05:00,DGX,positive
358004.0,"Zacks Sell List Highlights: True Religion Apparel, Crucell N.V. (ADR), Liz Claiborne, Inc. and Quest Diagnostics Inc  - Press Releases",2010-11-18 10:36:00-05:00,DGX,positive
358005.0,"Zacks Sell List Highlights: True Religion Apparel, Crucell N.V. (ADR), Liz Claiborne, Inc. and Quest Diagnostics Inc  - Press Releases",2010-11-18 05:01:00-05:00,DGX,positive
358006.0,LabCorp Raises Funds - Analyst Blog,2010-11-17 14:30:00-05:00,DGX,neutral
358007.0,Jefferies Maintains Hold on Quest Diagnostics,2010-11-17 09:15:00-05:00,DGX,neutral
358008.0,LabCorp Raises Funds - Analyst Blog,2010-11-17 09:14:00-05:00,DGX,neutral
358009.0,"Top 4 Stocks In The Medical Laboratories & Research Industry With The Highest Cash (ALR, PPDI, CVD, DGX)",2010-11-10 03:52:00-05:00,DGX,positive
358010.0,Calls Purchased on Quest Diagnostics (DGX),2010-10-27 12:34:00-04:00,DGX,neutral
358011.0,Standpoint Initiates Buy Rating on Quest Diagnostics (DGX),2010-10-22 11:04:00-04:00,DGX,neutral
358012.0,Quest Beats but Lowers Rev Guidance - Analyst Blog,2010-10-20 18:54:00-04:00,DGX,negative
358013.0,Earnings Preview: Quest Diagnostics - Analyst Blog,2010-10-19 16:09:00-04:00,DGX,neutral
358014.0,American Medical Association To Offer Services on New Online Physician Platform,2010-10-15 10:27:00-04:00,DGX,neutral
358015.0,Highlights From DGX's Management Meetings,2010-10-05 08:51:00-04:00,DGX,neutral
358016.0,"Kaufman Bros. Initiate Coverage For LH, DGX",2010-09-29 09:14:00-04:00,DGX,neutral
358017.0,The Diagnosis Looks Favorable for Quest Diagnostics (DGX),2010-09-22 12:03:00-04:00,DGX,positive
358018.0,August Physician Office Visits Data Improves Slightly From Deutsche Bank ,2010-09-21 07:58:00-04:00,DGX,positive
358019.0,LabCorp to Acquire Genzyme Genetics - Analyst Blog,2010-09-13 15:15:00-04:00,DGX,neutral
358020.0,Quest Diagnostics (DGX) - Bear of the Day,2010-08-10 04:04:00-04:00,DGX,neutral
358021.0,Celera Misses; Lowers Guidance - Analyst Blog,2010-08-04 15:32:00-04:00,DGX,negative
358022.0,"Zacks Bull and Bear of the Day Highlights: Jabil Circuit, Quest Diagnostics, Ford, Toyota and Chesapeake Energy   - Press Releases",2010-08-02 11:12:00-04:00,DGX,positive
358023.0,Quest Diagnostics (DGX) - Bear of the Day,2010-08-02 06:10:00-04:00,DGX,neutral
358024.0,Earning Scorecard: Quest Diagnostics - Analyst Blog,2010-07-30 14:00:00-04:00,DGX,neutral
358025.0,"DGX Posts Higher-Than-Expected Q2 EPS, Reduces 2010 Projections",2010-07-21 08:49:00-04:00,DGX,neutral
358026.0,"DGX Posts Q2 EPS Above Consensus, Lowers 2010 EPS Guidance",2010-07-21 07:17:00-04:00,DGX,negative
358027.0,Calls Sold on Quest Diagnostics (DGX),2010-07-19 11:45:00-04:00,DGX,neutral
358028.0,Mixed Economic News  06-25-2010,2010-06-25 14:59:00-04:00,DGX,neutral
358029.0,"Mad Money Lightning Round: Jim Loves NFLX, DGX, PXD, APC, EMC, HGSI",2010-04-22 07:53:00-04:00,DGX,positive
358030.0,"Mad Money Lightning Round Recap (NFLX,  DGX, PXD, EMC, HGSI, DNDN)",2010-04-21 20:27:00-04:00,DGX,negative
358031.0,Before Jumping Into A Single Health Care Stock Consider This ETF,2010-03-23 23:22:00-04:00,DGX,positive
358032.0,Investors Flock To Healthcare ETFs On Historic Reform,2010-03-22 16:13:00-04:00,DGX,neutral
358033.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,DGX,positive
358034.0,Weak Top-Line Trends Pressure DGX Stock,2010-01-26 09:45:00-05:00,DGX,negative
358035.0,Quest Dazzles (DGX),2010-01-25 14:25:00-05:00,DGX,neutral
358036.0,"Company News for January 25, 2010 - Corporate Summary",2010-01-25 09:26:00-05:00,DGX,neutral
358037.0,"Earnings Overview For Companies Reporting Today (ETN, HAL, DGX, ERIC, TXN, AMGN, AAPL)",2010-01-25 08:34:00-05:00,DGX,neutral
358038.0,"Benzinga’s Earnings Roundup (CNH, ETN, DGX, HAL, PVTB, SEE)",2010-01-25 08:02:00-05:00,DGX,neutral
358039.0,DGX Growth Outlook Improves,2009-12-10 13:26:00-05:00,DGX,positive
358040.0,"Cramer Likes DGX, FNFG and Dislikes NYB, DYN",2009-10-08 09:13:00-04:00,DGX,neutral
